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ABSTRACT

Apoptosis, a form of physiological cell death, has been found to occur during
regression of the corpus luteum (Juengel eta/, 1993; Dharmarajan eta/, 1994).
The pathways involved in this process, however, have yet to be specified. One
possible mediator of corpus luteum regression is the Fas (or AP0-1 or CD95)
receptor, a transmembrane protein which induces apoptosis in the cell when
ligated.

In order to further confirm this hypolhesis, the present study

establishes and quantitates the presence and regulation of Fas receptor and
Fas ligand (Fasl) in the rat corpus luteum during pregnancy and post-partum.
The animals used were sexually mature (1 0-12 week old) female Wistar rats.
The presence of Fas and Fasl in the rat corpus luteum at various stages of
pregnancy and post-partum was investigated by immunohistochemistry using
an anti-Fas monoclonal antibody and an anti-FasL polyclonal antibody. FasL
was localised in corpora lutea throughout pregnancy, whilst Fas was localised
at day 1 of pregnancy and at the time of luteolysis. Information on the steady
state mRNA levels of Fasl was obtained using relative quantitative reverse
transcription PCR (RT-PCR) analysis of RNA isolated from rat ovaries at
various stages of pregnancy and post-partum.

Expression of Fasl mRNA

increased significantly at day 22 of pregnancy, just prior to parturition, and
decreased by day 3 post-partum.

The ability of an anti-rat Fas monoclonal

antibody to block spontaneous apoptosis in corpora lutea placed in an in vitro
culture model with serum-free medium was examined by analysis of extracted
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DNA using 3'-end labelling.

Treatment with an anti-rat Fas monoclonal

a11tibody demonstrated a reduction in the occurrence of spontaneous
apoptosis. Roles for Fas receptor and Fas ligand in corpus luteum function
were proposed, and the suitability of the

in vitro corpus luteum culture model for

future studies investigating molecular mechanisms of Fas-mediated apoptosis
in the corpus luteum was discussed.
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1.

INTRODUCTION

Apoptosis, a form of physiological cell death, allows tissue remodelling
and cellular replacement to occur quickly, without damaging surrounding tissue.
It can be distinguished from necrosis, which is cell death resulting from physical
injury

or

trauma,

by

morphological

characteristics

such

as

cellular

condensation, membrane blabbing, cleavage of DNA into oligomers of 185
base pair fragments, and packaging of cellular contents into membrane-bound
apoptotic bodies.

These apoptotic bodies are phagocytosed by surrounding

cells or macrophages.

Examples of apoptotic cell death occur during

development (Hurle, 1988; Clarke, 1990), in the elimination of autoreactive T
and 8 lymphocytes (MacDonald and lees, 1990) and during the degradation of
rabbit uterine epithelium following ovariectomy (Rotella et a/, 1989).

One of the physiological processes in which apoptosis has been
implicated is regression of the corpus luteum, an organ within the ovary which
differentiates from the ruptured follicle following ovulation. The main function of
the corpus luteum is secretion of progesterone, to maintain the lining of the
uterus for implantation and for the support of a fertilised ovum. Regression of
the corpus luteum occurs at the end of each ovarian cycle or when it is no
longer required for the maintenance of pregnancy (Johnson and Everitt, 1995,
pg. 71-72).

little is known about the mechanisms involved in this process,

however apoptotic cell death has been found to occur during luteal regression
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in cattle (Juengel et a/, 1993), pseudopregnant and pregnant rabbits
(Dharmarajan eta/, 1994; Dharmarajan eta/, 1997), pregnant rats (Ke el a/,
1997; Sridaran el a/, 1997) and marmoset monkeys (Fraser eta/, 1995).

As a range of stimuli may trigger apoptosis and many molecular
pathways have been identified which facilitate apoptotic cell death, it is
necessary to identify the mediator(s) of apoptosis in regressing luteal cells.
One possibility is the Fas (or AP0-1 or CD95) receptor, a transmembrane
protein which induces apoptosis in the cell following ligation.

Although the

exact mechanisms by which the Fas I Fas ligand system induce apoptosis have
yet to be ideiiiiHed, it is known to be utilised extensively by the cells of the
immune system (Watanabe-Fukunaga et al, 1992; Ju et a/, 1995; Dhein et a/,
1995; Oshimi eta/, 1996).

Within the reproductive system, the expression of mRNA for the Fas
receptor has been detected in the mouse ovary (Watanabe-Fukunaga el a/,
1992), and Fas appears to be involved in the regression of vaginal epithelium
following ovariectomy and during the estrus cycle in the mouse (Suzuki et a/,
1996). Fas receptor mRNA is also expressed by human granulosa and luteal
cells, and Fas monoclonal antibodies can induce apoptosis in these cells when
they are pretreated with interferon gamma in culture (Quirk et a/, 1995). In
addition, abundant expression of the Fas receptor in the regressing corpus
luleum of the normal adult human ovary has been reported (Kondo eta/, 1996).
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These findings indicate that Fas-mediated apoptosis may have a role in
the mechanisms of regression of the corpus luteum.

The present study

examined the regulation of Fas receptor and Fas ligand in the rat corpus luteum
during pregnancy and post-partum to examine this hypothesis. AI the same
time, the suttability of the in vitro corpus luteum culture model for future studies
into the mechanisms of Fas-mediated apoptosis in the corpus luleum was

assessed.
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2.

LITERATURE REVIEW

2.1.

Introduction

Regression of the corpus luteum involves the death of considerable
numbers of cells and significant tissue remodelling within a short period of time.
The mechanisms contributing to luteolysis {functional and structural regression
of the corpus luteum) are not well understood and many factors appear to
interact to produce the changes seen in this process. Although apoptosis of
luteal cells occurs at the time of regression, the pathways involved have yet to
be identified. Recent studies indicate that the Fas receptor, a transmembrane
protein capable of inducing apoptosis in the cell when ligated, is expressed by
luteal cells at the time of regression, thus providing a rationale for further
studies into the role of the Fas I Fas ligand system in corpus luteum function.

2.2.

The Corpus Luteum

2.2.1. Background

The corpus luteum, an organ within the ovary which differentiates from
granulosa and lutein cells of the ruptured follicle following ovulation, is essential
for successful reproduction in mammals. Its main function is secretion of the
steroid hormone progesterone, which maintains the uterine lining in a state
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ready for implantation and development of a fertilised ovum. Towards the end
of each ovarian cycle or when no longer required for the maintenance of
pregnancy, the corpus luteum undergoes functional regression, when the
amount of progesterone secretion is dramatically reduced. This is followed by
structural regression, with degeneration of the luteal cells. Figure 1 illustrates
the levels of progesteron~ sncretion throughout the 23 days of rat pregnancy.
Note that the levels are highest at around day 16 of pregnancy and they decline
dramatically just prior to parturition.

Whilst functional regression is necessary to allow the next ovarian cycle
to commence, structural regression is also essential, as the ovary must rid itself
of obsolete tissue in order to maintain its uniform size in relation to other
organs.
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FIGURE 1:

Serum Levels of Progesterone Throughout Rat Pregnancy
(SOURCE: Uchida et al, 1970)
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2.2.2. The Rat Estrus Cycle

The following section outlines the nature of the estrus cycle and
histology of the rat corpus /Uteum, as natural regression of the pregnant rat
corpus /Uteum was the model used for this study.

The estrus cycle of the rat generally lasts for four days and comprises
four stages.

Proestrus is characterised by the rapid growth of follides and

regression of corpora lutea from the previous cycle. The follicles then grow to
their maximum size during estrus.

Ovulation occurs early in the next stage,

metestrus. In the latter part of this stage new corpora lutea are formed from
differentiated granulosa and lutein cells of the ovulated follicles.

During

diestrus, the newly formed corpora lutea and follicles for the next cycle grow
(Hebel and Stromberg, 1986, pg. 231 ).

Corpora lutea from previous cycles regress slowly in the rat, so that
three or more generations can be seen in the ovary at any time during a
specific estrus cycle (Hilliard, 1973).

After several cycles the corpora lutea

involute, form scar tissue which is known as corpora albicans, and eventually
disappear. Figure 2 depicts a whole ovary from a rat at day 22 of pregnancy
and the histology of the rat ovary. Individual corpora /Utea which have been
dissected from a rat ovary and the histology of the corpus luteum are shown in
Figure 3.
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The gestation time in rats is 23 days, with the corpus luteum reaching
maximum function at day 16 of pregnancy, as illustrated in Figure 1. Functional
regression of the corpus luteum, evidenced by a decrease in progesterone
secretion, begins two to three days before parturition. The number of luteal
cells in the rat corpus luteum stays constant (Meyer and Bruce, 1979;
Dharmarajan et a/, 1989), indicating that cell death does not occur at this time.
Structural regression of luteal cells becomes apparent at day 1 post-partum and
the weight of the corpus luteum of pregnancy continues to decline over
numerous estrus cycles following parturition (Taya and Greenwald, 1982).

s
F

CL
CL
(a)
FIGURE 2:

(b)

The Rat Ovary
(a)
Whole Ovary From a Rat at Day 22 of Pregnancy.
(b)
Section of Rat Ovary Stained with Haematoxylin and Eosin,
1Ox. CL- Corpus Luteum, F - Follicle, S - Stroma.
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•
(a)
FIGURE 3.

The Rat Corpus Luteum
(a)
Individual Corpora Lutea Dissected from a Rat Ovary at
Day 22 of Pregnancy.
(b)
Section of Rat Corpus Luteum Stained with Haematoxylin
and Eosin, 40x. Arrows - Luteal Cells, Arrowheads Endothelial Cells.

2.2.3. Proposed Mechanisms of Corpus Luteum Regression

Hormonal influences in luteolysis differ from species to species and are
not well characterised.

The reduction in progesterone secretion prior to

luteolysis has been attributed to secretion of prostaglandin F2a. in the sheep,
cow, guinea-pig and horse (Johnson and Everitt, 1995, pg. 72), however a
similar signal in other mammals has not been identified.

Thus, luteolysis in

some species may be initiated by withdrawal or insufficient supply of
luteotrophic substances, whilst in others luteolysis follows the release of a
luteolytic substance.

The matter is further confused by .evidence that some

luteotrophic hormones may have luteolytic properties, either through an age
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dependent differential reaction by the luteal cells, or when in combination with
other hormones (Hilliard, 1973).

Whatever the initial hormonal influence, regression of the corpus luteum
is a cyclic event which occurs in all mammals.

Cellular and molecular

mechanisms proposed to be involved in luteal cell regression (Juengel et a/,
1994) include:
(1)

reduction of blood flow,

(2)

formation of oxygen radicals, and

(3)

infiltration of immune cells.

Reduction of blood flow to the corpus luteum at the time of regression
could be expected to have a role in luteolysis, by diminishing the amounts of
luteotrophic substances available to luteal cells. Rates of blood flow in relation
to functional regression of the corpus luteum have been investigated by many
researchers using various animals and models of regression, with variable
results reported (Bruce et a/, 1984). In the rat, blood flow to the corpus luteum
did not appear to be reduced in natural regression at the end

of

pseudopregnancy (Pang and Behrman, 1979) or pregnancy (Bruce eta/, 1984).
Nor was it reduced by prostaglandin-induced regression (Pang and Behrman,
1981). Furthermore, examination by light microscopy showed no evidence of
vascular degeneration during natural regression of the pregnant rat corpus
luteum (Bruce eta/, 1984). Thus blood flow does not appear to be a significant
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factor in corpus luteum regression in the rat (Bruce el a/, 198~' although it may
have a role in luteolysis in other species.

Oxygen radicals and reactive oxygen species are highly charged and/or
reactive products of physiological chemical processes produced in cells during
aerobic metabolism. They are capable of causing damage to tissue due to their
highly reactive nature.

Consequently,

cells have developed defence

mechanisms, such as antioxidant enzymes. Research indicates, however, that
oxygen radicals and reactive oxygen species assist in a variety of reproductive
functions, including capacitation (a process involving plasma membrane
changes to spermatozoa so that they are able to fertilise an ovum), the binding
of spemn to the zona pellucida of the ovum, and ovulation (Riley and Behrman,
1991). Small amounts of hydrogen peroxide, a reactive oxygen species, have
been shown to exert luteolytic effects on rat ovarian cells (Behrman and
Preston, 1989). Also, production of hydrogen peroxide rapidly increases in rat
ovaries

during

the

natural

luteal

regression

that

occurs

in

late

pseudopregnancy, and in regression induced by treatment with prostaglandin

F,. (Riley and Behrman, 1991), further indicating a role in luteolysis.
As granulosa cells do not differentiate into luteal cells until the onset of
sexual maturation, luteal tissue Is not present during the time that the immune
system is adapting to "self'. This unique characteristic of the corpus luteum has

led to the proposal that immune mechanisms may be involved in corpus luteum
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regression (Bukovsky

et at,

1995), and numerous studies indicate that the

immune system may have a role in luteolysis. Bukovsky
(cited in Bagavandoss

et at,

et

a/ found in 1977

1990) that existing corpora lutea persisted in adult

rats treated with antithymocyte serum.

Both macrophages and activated T

lymphocytes were present in the rabbit corpus luteum throughout the luteal
phase, with the number of macrophages increasing significantly during the
latter stages of regression, both in pseudopregnancy and following parturition
(Bagavandoss

et at,

1990). Further, Class II major histocompatibility complex

(MHC) antigens, which activate

T lymphocytes when presented by cells in

conjunction with antigens that trigger immune responses, have been identified
in:
• human granulosa cells with autoimmune dysfunctiOn (Hill

el at,

1990),

• cultured bovine luteal cells treated with interferon gamma (Fairchild and
Pate, 1989),
• bovine large luteal cells, increasing throughout the estrus cycle to reach a
maximum before luteolysis (Fairchild Benyo

et at,

1991),

• the rat corpus luteum during pregnancy and pseudopregnancy, increasing at
the time of luteolysis (Branstrom

et at,

1994), and ·

• human granulosa lutein cells, substantially increasing during the late luteal
phase (Bukovsky et a/, 1995).
Fairchild Benyo

et a/ (1991)

hypothesised that the expression of Class II MHC

antigens on luteal cells potentiates immune responses involved with luteolysis.
Whilst T lymphocyte infiltration of the corpus luteum did not appear to ~Iter
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significantly throughout the luteal phase in rats (Branstrom et al, 1994), these
cells were present in the regressing corpus luteum of the rabbit (Bagavandoss

eta/, 1988), and human (Bukovsky el a/, 1995). Thus, from research to dale,
immune cells do appear to have a role in corpus luteum function which could be
related to a reduction in progesterone secretion and/or luteolysis.

It is important to note that each of the above proposed mechanisms
involved in luteal regression are not mutually exclusive.

Indeed, immune

mechanisms could possibly lead to vascular degeneration and increased
concentrations of oxygen radicals.

The apoptosis which occurs during

luteolysis may be triggered by one, or a combination, of these factors or by
conditions yet to be identified.

2.3.

Apoptosis

2.3.1. Background

Since the advent of the cell theory in the nineteenth century, scientists
have known that all cells must eventually die.

Before the early 1970's,

however, most research into cell death focused either on necrosis, cell death
resulting from physical insults, such as trauma, infectious agents and exposure
to toxins, or on the mechanisms of ageing. The significance of physiological
cell death was not fully realised until after the process was characterised
morphologically by Kerr eta/ (1972). This regulated process of cell death was
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named apoptosis from the Greek word for falling (as does a leaf from a tree),
referring to detachment of the dying cells from the extracellular matrix.

Apoptosis is necessary for normal function in organisms as it allows
tissue remodelling and cellular replacement to occur quickly

will! little or no

damage to surrounding cells. It is also a pathway which may be taken by cells
which have been significantly, but not fatally, damaged by physical insult.
Examples of apoptotic cell death occur during development (Hurle, 1988;
Clarke, 1990), in the elimination of autoreactive T and 8 lymphocytes
(MacDonald and lees, 1990; Sambhara and Miller, 1991), during the
degradation of endometrial cells (Rotella et a/, 1989), and in cytotoxic T
lymphocyte-mediated killing of target cells (Cohen eta/, 1985).

Cell death by apoptosis follows from a range of stimuli or from the
withdrawal of growth factors. Depending on the cell type and stimuli, apoptotic
cell death may occur by a variety of molecular pathways, however, the
observed morp:1ological characteristics are generally uniform.

Induction

involves the activation of specific proteins which function in various aspects of
this process. Occurring in single cells or small clusters of cells, apoptosis is
characterised by cellular condensation, membrane blebbing, cleavage of DNA
into oligomers with multiples of 185 base pair fragments (the DNA is cleaved at
internucleosomal sites), and packaging of cytoplasmic and nuclear contents
into membrane-bound vessels known as apoptotic bodies. Surrounding cells or
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macrophages phagocytose these apoptotic bodies, preventing the release of
harmful cellular contents in the extracellular matrix.

Identification and confirmation of apoptotic cell death can be wovided by
a variety of methods. Those most commonly used include the observation of
morphological characteristics, 3'-end labelling, in situ labelling of double strand
DNA breaks with terminal deoxynucleotidy/ transferase-mediated dUTP biotin
nick end-labelling (TUNEL), and the comet assay. Tl,3 morphology of dying
cells can be viewed by light or electron microscopy.

As stated previously,

features which distinguish apoptotic cells from necrotic cells include the
presence of cellular condensation, chromatin condensation,

membrane

blebbing and the production of apoptotic bodies. By comparison, cells dying by
necrosis are evidenced by cellular swelling, lysis of the cells and the presence
of inflammation in the surrounding tissue. Viewing the morphology of cells is an
important and useful tool to confirm apoptotic cell death in the tissue of interest,
as cell types and locations can be identifled. This technique, however, is not a
practical choice for use in quantitative studies, as morphological characteristics
of apoptosis may only be seen in a small number of cells at any one time and
cell counting methods are lime-consuming.

Both 3'-end labelling and TUNEL involve labelling of DNA which has
been fragmented. DNA extracted from tissue is used for 3'-end labelling, where
the 3'-ends of cleaved DNA are labelled with a radioactive nucleotide (a"P-
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ddATP). The labelled DNA is fractionated on an agarose gel from which an
autoradiograph is developed.

DNA from cells undergoing apoptosis show

ladders with multiples of around 185 base pairs in size, indicating that the DNA
has been cleaved at intemucleosomal sites, while DNA from necrotic cells is
characterised by a smear, indicating the random breakdown of genetic material
which occurs in this type of cell death (Tilly and Hsueh, 1993). The 3'-end
labelling technique is a useful tool for quantitative analysis of the extent of
apoptosis, as the low molecular weight DNA bands from each lane in an
agarose gel can be excised and counts per minute obtained from a scintillation
counter.

This method, however, cannot confirm which cell types in tissue

samples are dying by apoptosis. On the other hand, TUNEL does allow the
identification of which cells are dying, but does not distinguish between
apoptosis and necrosis (Hsueh el a/, 1994).

The comet assay involves

electrophoresis of cell preparations to draw charged DNA from the cell nucleus
(Fairbairn el a/, 1995). Fragmented DNA forms a characteristic "comet-like" tail
as it migrates further than intact DNA, and so apoptotic cells can be rapidly
identified (Fairbairn el at, 1995). Two methods of detection are often used in
tandem, in order to balance the relative advantages and disadvantages of
each.
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2.3.2. Apoptosis and the Reproductive System

The reproductive system provides many examples of physiological
processes which require extensive tissue remodelling and cell death during
normal function. Thus, it is not surprising that the occurrence of apoptosis has
been confirmed in various reproductive cell types undergoing regression and
attrition. Numerous studies of the relationships between hormone-dependent
cells and apoptosis have been conducted.

In the male, apoptosis was found to occur in the ventral lobe of the rat
prostate gland following the post-castration cessation of testosterone secretion
(Kyprianou and Isaacs, 1988). The rat prostate has since been developed as
an in vivo model for studying molecular mecha~isms of apoptosis, as a
considerable number of cells undergo apoptosis and the length of time taken
for the ventral prostate cells to die is predictable (Colombe! and Buttyan, 1995).

Apoptosis has also been implicated in the deletion of germ cells during
normal spermatogenesis. Up to 75% of the potential number of mature sperm
which can be produced from germ cells in the adult testis are lost (Billig
1996).

et at,

The morphological characteristics observed in spermatogonial cell

death are the same as those described in cells undergoing apoptosis (Allan

at,

et

1992). Depletion of testosterone and gonadotropin by administration of an

antagonist to gonadotropin-releasing hormone was associated w~h a significant
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increase in apoptosis of germ cells, as detected by 3'-end labelling and TUNEL
(Hikim eta/, 1995; Brinkworth eta/, 1995). A role for apoptosis in prenatal male
gonads has also been suggested, with the identification of apoptotic
morphology in embryonic germ cells of the male mouse (Coucouvanis et a/,
1993). Follicle stimulating hormone (FSH) has been shown to influence the
survival of germ cells in both immature and adult rats, with apoptosis (again
evaluated by 3'-end labelling and TUNEL) increasing when FSH was
specifically immunoneutralised (Shelly et a/, 1996).

Further, in samples of

semen collected from a human fertility centre, a correlation was found between
the percentage of sperm cells which showed characteristics associated with low
fertility and the percentage of sperm cells which stained posttive for DNA strand
breaks using TUNEL (Gorczyca et a/, 1993).

The authors concluded that

apoptosis may be involved in the physiological deletion of germ cells, possibly
to eliminate defective cells (Gorczyca et a/, 1993), however, other detection
methods for apoptosis would need to be used to confirm this suggestion.

Apoptosis has also been found to occur in the female reproductive
system and, as in the male, hormonal control does appear to influence
physiological cell death in some situations. Ovariectomy, for example, results
in apoptosis of uterine epithelial cells in rabbits (Rotello eta/, 1989).

One of the most striking examples of tissue loss over time occurs in the
ovaries of mammals.

Before the onset of ovulation, 99.9% of the follicles
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present in human ovaries at birth degenerate by a process known as atresia
(Hsueh eta/, 1994). In 1991, Hughes and Gorospe showed by identification of
morphological characteristics and use of 3'-end labelling that rat granulosa cells
of follicles induced to degenerate appear to undergo apoptosis. Similar findings

were published by Tilly eta/ in the same year with naturally atretic chicken and
porcine follicles. Hormones were found to control apoptosis in granulosa cells,
with oestrogens preventing apoptosis and testosterone negating the effects of
oestrogens (Billig eta/, 1993). Whilst Billig eta/ (1993) found that progesterone
had no effect on granulosa cell apoptosis, Peluso and Pappalardo (1994)
reported that progesterone reduced the incidence of apoptosis in cultured rat
granulosa cells and, further, that adhesion between cells enhanced the antiapoptotic effects of progesterone.

2.3.3. Apoptosis in the Corpus Luteum

The first molecular evidence that luteal cells may undergo apoptosis was
presented by Zeleznik et a/ (1989).

Similartties in descriptions of the

histological changes occurring in the corpus luteum during the luteal phase of
pregnancy (Corner, 1956), and the cellular changes associated with apoptosis
(Kerr eta/, 1972), prompted Zeleznik eta/ (1989) to investigate the occurrence
of apoptotic degeneration in luteal cells.

As stated previously, one of the

characteristics of apoptosis is the cleavage of DNA into oligomers of 185 base
pairs.

Cohen and Duke (1984) identified an endonuclease capable of
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fragmenting DNA in this manner, so Zeleznik et a/ (1989) searched for, and
detected, Ca"/Mg"-dependent endonuclease activity in differentiated rat
granulosa cells, but not in undifferentiated gransulosa cells.

Interestingly, a

calcium ionophore had been shown to mimic the luteolytic effects of
prostaglandin F2, (PGF,,) in isolated luteal cells (Baum and Roseberg, 1977),
perhaps because

~

activated an endonuclease responsible for DNA cleavage in

apoptosis.

That luteal cells were actually capable of dying by apoptosis was initially
confirmed by Juengel eta/ (1993). In both spontaneous and PGF,,-induced
luteal regression in cattle, apoptosis, detected by fractionating DNA on an
ethidium bromide-stained agarose gel or 3'-end labelling, occurred after
progesterone serum levels had begun to decrease.

Hence, Juenger et a/

(1993) proposed that apoptosis was instrumental during structural regression of
the corpus luteum but not during functional regression. This study also found
that capillaries within the corpus luteum disappeared before fragmented DNA
could be detected, indicating that endothelial cells were not undergoing
apoptosis at the time of structural regression of luteal cells. II is possible that
the decrease in progesterone secretion by luteal cells, or the disappearance of
endothelial cells in the corpus luteum, may be early triggers leading to the
apoptotic cell death seen in structural regression in cattle (Juengel eta/, 1993).
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In contrast, a correlation between the occurrence of apoptosis and
functionalluteolysis in the pseudopregnant and pregnant

rab~it

ovary has been

found (Dharmarajan eta/, 1994; Dharmarajan eta/, 1997). An analysis of DNA
integrity by TUNEL confirmed that those cells undergoing DNA fragmentation
were luteal cells (Dharmarajan eta/, 1994). The in vitro corpus luteum culture
model was developed following the discovery that spontaneous apoptosis
occurred in rabbit corpora lutea cultured in serum-free medium. This model
was used to show that treatment with human chorionic gonadotropin, the
hormone which sustains luteal function during the first trimester of pregnancy in
humans,

could

suppress

apoptosis

in

cultured

rabbit

corpora

lutea

(Dharmarajan eta/, 1994).

Recently, in vivo treatment of rat corpora lutea with a gonadotropinreleasing hormone agonist during early pregnancy was found to induce
apoptosis in luteal cells (Sridaran et a/, 1997). The same study found that
spontaneous apoptosis of luteal cells could be induced by culturing rat corpora
lutea in serum-free medium (Sridaran eta/, 1997). An analysis of DNA integrity
by TUNEL indicated that some apoptosis is occurring at day 22 of rat
pregnancy, increasing by day 1 post-partum (Ke eta/, 1997).

Corpora lutea of marmoset monkeys undergoing induced regression
following administration of either a PGF,. analogue or gonadotropin-releasing
hormone antagonist, showed morphological features in some degenerating
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luteal cells which were characteristic of apoptosis, whilst other luteal cells
appeared to be dying by necrosis (Fraser eta/, 1995). Unfortunately, further
experiments to confirm that apoptotic cell death was occurring, and to identify
the extent of apoptosis, were not undertaken.

In summary, apoptosis has been found to occur during luteolysis in a
range of mammalian species.

The mechanisms and pathways involved in

apoptotic cell death in the corpus luteum, however, have yet to be identified.

2.4.

The Fas I Fas Ligand System

As stated in the previous section, the molecular pathway by which
apoptosis occurs is dependent upon the cell type involved and the stimuli
received.

Thus, luteal cells undergoing apoptosis may use one of many

pathways, or perhaps more than one pathway, during regression. One possible
mediator involved in corpus luteum regression is the Fas (or AP0-1 or CD95)
receptor, a transmembrane protein which induces apoptosis in the cell when
ligated.

2.4.1. Background

In 1989 two separate research groups developed mouse monoclonal
antibodies, named Fas (Yonehara eta/, 1989) and AP0-1 (Trauth eta/, 1989),
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which were capable of inducing apoptosis in some human cell lines.

The

cytolytic activity was particularly apparent when the cells were also treated with
interferon gamma (Yonehara el a/, 1989). These antibodies had two possible
modes of action: they either bound to an antigen which was a receptor with
cytolytic activity and acted as a ligand by inducing apoptosis, or the antibodies
bound to an antigen which was a receptor for a growth factor or a molecule
essential for transduction of a growth signal, blocking the signal and causing
cell death. Expression of human Fas eDNA in mouse cell lines made the cells
susceptible to death induced by the Fas monoclonal antibody, indicating that
the Fas receptor did transduce an apoptotic signal to the cell (Itch el a!, 1991).
The Fas receptor was classified as a type I membrane protein (because the Nterminal of the protein was extracellular and the C-terminal lay within the cell),
belonging to the tumour necrosis factor (TNF) receptor family. This grouping
includes TNF receptor I (also capable of inducing cell death) and II, nerve
growth factor receptor and lymphocyte antigens such as CD40 and OX40 (Itch
eta/, 1991). Subsequently, the Fas and AP0-1 antibodies were found to act
upon the same receptor (Oehm el a/, 1992).

Fas antigen mRNA expression was detected in the mouse thymus,
heart, liver and ovary (Watanabe-Fukunaga el a/, 1992), indicating that it was
possibly involved in a variety of apoptotic processes. Deletion of a region at the
C-terminus of Fas showed that this area was necessary for the transduction of
cytolytic activity (Itch and Nagata, 1993). Homology to the TNF receptor I was
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significantly conserved in this region and the 68 constituent amino acids were
termed the "death domain", highlighting their function in transducing an
apoptotic signal to the cell (ltoh and Nagata, 1993).

Fas ligand, cloned in 1993, was found to be a type II transmembrane
protein belonging to the TNF family (Suda ef a/, 1993). The structure and
properties of Fas ligand were similar to those of TN Fa (for example, Fas ligand
appeared to function as a trimer and overexpression of the protein resulted in
shedding of a soluble form which was capable of inducing apoptosis), but Fas
ligand specifically activated the Fas receptor (Suda et at, 1993). Fas ligand
mRNA expression in the rat was detected in spleen, testis, small intestine,
kidney and lung (Suda eta/, 1993).

As Fas and TNF had many similarities, Clement and Stamenkovich
(1994) compared the two by transfecting fusion proteins consisting of the
extracellular region of CD40 and the transmembrane. and intracellular regions of
Fas receptor, TNF I receptor or TNF II receptor into a human melanoma cell
line which did not express these proteins. Cells were treated with the CD40
ligand and differences in the rates of cell death examined. While Fas receptor
was capable of killing most cells within hours, the TNF receptors required two to
three days of treatment with the CD40 ligand for cytotoxicity to occur (Clement
and Stamenkovich, 1994), indicating either that different molecular mechanisms
were involved in the induction of apoptosis or that the TNF receptors induced
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apoptosis following a convoluted series of steps, whilst Fas-metJiated apoptosis
directly and immediately triggered the cell death pathway.

2.4.2. Fas and Fas Ligand in the Immune System

In the few short years since the Fas/Fas ligand system was discovered
and characterised many important functions within the immune system have
been shown to involve Fas-mediated apoptosis. The physiological significance
of Fas expression in the thymus was first realised when it was found that mice
carrying the lymphoproliferation (lpr) mutation had defects in the gene for Fas
receptor (Watanabe-Fukunaga et a/, 1992).

Lymphoproliferation disorder in

mice resembles human systemic lupus erythematosus and is characterised by
lymphadenopathy, splenomegaly, production of many autoantibodies and the
development of nephritis or arthritis (Watanabe-Fukunaga eta!, 1992). Further
evidence for this proposal was presented when generalised lymphoproliferative
disease (gld)

in

mice,

also

characterised

by

lymphadenopathy

and

splenomegaly, was found to result from a point mutation in the gene coding for
Fas ligand (Takahashi eta!, 1994). The phenotypes' indicate that Fas-mediated
apoptosis is used in the thymus to delete negatively selected T cells which
react to "selF antigens.

T-cell mediated cy1otoxicity, previous!)• thought to result only from
formation of perforin pores in target cells, can occur by the Fas/Fas ligand
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system. Fas-mediated apoptosis of target cells was. demonstrated by cytotoxic
T lymphocytes incapable of killing using perforin pores (Kagi et a/, 1994).
Target cells from lpr mutant mice, however, could not be killed by these T cells
(Lewin eta/, 1994). Thus, cytotoxic T lymphocytes are capable of expressing
Fas ligand in order to induce apoptosis in target cells which express the Fas
receptor. More recently, human natural killer cells have also been shown to be
capable of inducing apoptosis in target cells by expression of Fas ligand
(Oshimi eta/, 1996).

As both lpr and gld mice showed defects in the deletion of peripheral
activated T cells, a role for Fas in inducing apoptosis of activated T cells for
immune suppression was proposed (Dhein

et

a/, 1995; Ju

et

a/, 1995).

Activated T cells increased the expression of Fas receptor mRNA (Dhein et a/,
1995) and markedly increased the expression of Fas ligand mRNA (Ju

et a/,

1995). Also, the death of activated T cells could be prevented by treating cells
with an antibody capable of blocking Fas-mediated apoptosis (Dhein et a/,
1995; Ju

eta/,

1995).

In summary, Fas-mediated apoptosis has been shown to have significant
roles in immune system function,

including deletion of self-reactive T

lymphocytes in the thymus, T cell- and natural killer cell-mediated cytotoxicity
and immune suppression of activated T cells.

33

2.4.3. Fas Ligand and Immune Privilege

The ability of some tissue sttes to protect grafted tissue from rejection
and of some tissue types to be grafted wtthout being rejected is known as
immune privilege.

Attacks by the immune system in response to foreign

antigens invariably result in damage to surrounding tissue and inflammation. In
delicate or non-dividing tissue, as is found in the eye" and brain, the effect of the
cure may be worse than the cause. Also, in the case of pregnancy, foreign
tissue must be accepted for successful reproduction. Protection from damaging
immune reactions is achieved by a variety of physiological means, including
blood-tissue barriers and immune suppression.

The expression of Fas ligand to facilitate the killing of activated T cells
displaying the Fas receptor has been proposed as another mechanism of
immune privilege (Bellgrau et a/, 1995; Griffith et a/, 1995). In confirmation,
Sertoli cells of the testis express Fas ligand and are able to survive indefinitely
when transplanted in the kidney capsule of allogeneic animals, whilst Sertoli
cells from gld mice (which express non-functional ligand) are rejected (Bellgrau

eta/, 1995). Further, Griffith eta/ (1995) performed a series of experiments
implicating Fas ligand-mediated immune privilege in the mouse eye. Both Fas
ligand mRNA and protein were expressed in the eyes of normal mice.
Inflammatory cells entering the anterior chamber of the eye in normal mice, but
not in gld mice, died. No immune response was detected in the virally infected
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eyes of normal mice, whereas gld mice exhibited inflammation and survival of
immune cells in similarly infected eyes. Also, Fas-positive tumour cells died
when exposed to isolated anterior segments of the eye in normal mice but not
in gld mice, and Fas-negative tumour cells did not die (Griffith eta/, 1995).
Unfortunately, the mechanism(s) of cell death were not confirmed as being
apoptosis, as the authors analysed DNA fragmentation by TUNEL alone.

Fas ligand has also been detected in human cytotrophoblasts of first
trimester placental tissue sections and syncytiotrophoblasts of term placenta by
immunohistochemical staining and Western

blotting, indicating that its

involvement in immune privilege may also extend to protection of the foetus
(Runic eta/, 1996).

2.4.4. Fas and Fas Ligand in the Reproductive System

Fas and Fas ligand mRNA and protein is. expressed in a range of
reproductive tissues (Watanabe-Fukunaga et al, 1992; Suda et a/, 1993;
Bellgrau et a/, 1995; French et a/, 1996). Examination of their role in these
tissues, however, has only recently begun.

Steroid hormones such as testosterone, oestrogen and progesterone are
essential for normal reproductive functioning, not least because of their role in
the regulation of cell proliferation.

Removal of the gonads (and, therefore,
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cessation of testosterone secretion) in the normal male mouse resulted in
expression of Fas receptor and apoptotic regression of the prostate and
epididymis, whilst no regression was observed following gonadectomy of lpr
mice (Suzuki, Matsuzawa and Iguchi, 1996). Similarly, Fas expression was
increased and apoptotic cell death confirmed during ovariectomy-induced
regression of normal mouse vaginal epithelial cells, but changes were not
detected in lpr mice (Suzuki, Enari, Eguchi, Matsuzawa, Nagata, Tsujimoto and
Iguchi, 1996).

Abundant expression of Fas receptor in regressing corpora lutea and
atretic follicles of humans, as well as decreasing expression of Fas receptor in
maturing oocytes has been detected using immunohistochemistry (Kondo el a/,
1996). Confirmation of these findings was provided by Quirk eta/ (1995) who
found that Fas mRNA was expressed by human granulosa /luteal cells. This
study also showed that cultured granulosa I luteal cells pretreated with
interferon gamma were capable of undergoing apoptosis induced by a Fas
monoclonal antibody (Quirk el a/, 1995).

2.5.

Summary

The molecular mechanisms involved in regression of the corpus luteum,
an essential process in the female reproductive system, are not well
understood.

Although apoptosis has been shown to occur during luteolysis
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(Juengel et at, 1993; Dharmarajan eta/, 1994; Fraser eta/, 1995; Dharmarajan
eta/, 1997; Sridaran et at, 1997; Ke et at, 1997), the pathway(s) leading to cell

death have yet to be identified. Fas mRNA is expressed by human granulosa
and luteal cells, and Fas monoclonal antibodies are able to induce apoptosis in
these cells when they are pretreated with interferon gamma in culture (Quirk et
a/, 1995).

In addition, abundant expression of the Fas receptor in the

regressing corpus luteum of the normal adult human ovary has been reported
(Kondo et at, 1996). Further studies are required to examine the regulation of
both Fas receptor and Fas ligand in the naturally regressing corpus Juteum, and
to clarify the role of the FastFas ligand system in corpus luteum function.
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3.

ANIMALS

Throughout the research the experimental animals used were sexually
mature (10-12 week old) female Wistar rats. They were housed at 21•c with
55% humidity in

a 12 hours light I 12 hours dark cycle.

The feed was

autoclaved nonmal cubes and acidified water, both provided ad lib.

3.1.

Mating and Gestation

Five female rats were caged with one male rat overnight to allow mating
to occur. Day 1 was taken to be the day after successful mating. Rats were
considered to be pregnant if sperm were present in a vaginal smear on Day 1.
The gestation time for rats is 23 days (ie: the litter is born on day 23 of
pregnancy).

Table 1 shows the various pregnancy and post-partum stages

used throughout this study.

Table 1
Stages of Pregnancy and Post Partum in the Rat used for this Study

STAGE
Day 1
DayS
Day 16
Day22
Post-Partum Day 1
Post-Partum Day 3

ABBREVIATION
D1

DB
D16
D22
PP1
PP3

DESCRIPTION
The day after successful mating
8 days after successiul mating
16 days after successful mating
22 days after successful mating
1 day after birth of litter
3 days after birth of litter

38

3.2.

Tissue Collection

Rats were heavily anaesthetised with a mixture of halothane and nitric
oxide during the procedure. Ovaries and portions of spleen were excised as
quickly as possible and treated as required for the particular protocol b be
followed (either immunohistochemistry, RT-PCR or organ culture). After the
removal of tissue, rats were killed by administration of a lethal dose of
anaesthetic.
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4.

IMMUNOHISTOCHEMISTRY

4.1.

Rationale

Immunohistochemistry is an established, routine histological technique
used to identify antigens in tissue sections by means of antigen reaction with a
labelled primary or secondary antibody (Robinson

et a/,

1990, pg. 413). Not

only can the presence of Fas and Fas ligand be confirmed using this technique,
but the proteins can also be localised to particular cells in tissue sections.

Antibodies, which belong to a group of proteins called immunoglobulins,
are produced by B lymphocytes to bind selectively to foreign antigens. The
region on the antigen to which the antibody binds is known as an epitope.
There are an almost infintte number of antibodies which can be made, but
individual B lymphocytes can only make one specific antibody. When launching
an immune attack, a B lymphocyte is able to proliferate, forming clones which
all secrete the same specific antibody.

Antibodies

produced

for

immunohistochemistry

may

be

either

monoclonal or polyclonal. Monoclonal antibodies are produced by clones of
one B lymphocyte, so they bind with one specific epitope on an antigen.
Polyclonal antibodies are made by clones of different B lymphocytes which
react to a specific antigen, so they bind to a variety of epitopes on the one
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antigen (see Figure 4). As monoclonal antibodies bind to only one epitope,
there is less chance of non-specific binding or cross-reactivity compared to
polyclonal antibodies. However, if the epitope is.concealed by tissue fixation no
binding can occur, whilst polyclonal antibodies can bind to various epitopes
which may not have been concealed on the antigen. Also, the time and cost
involved in producing monoclonal antibodies is much higher than for polyclonal
antibodies.

Antigen

Epitopes

•

e

•

Antibody

(b)

(a)

FIGURE 4:

Monoclonal and Polyclonal Antibody Binding
(a)
Monoclonal antibodies bind to a specific epitope on an
antigen.
(b)
Polyclonal antibodies bind to various epitopes on an
antigen.

A variety of protocols have been developed for the detection of bound labelled
antibodies.

lmmunoenzymatic staining using the enzyme horse radish

peroxidase

and

the

chromogenic

substrate

3'3'-diaminobenzidine

tetrahydrochloride (DAB) was chosen for both the Fas receptor and Fas ligand.
The reaction between horse radish peroxidase and DAB in the presence of
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hydrogen peroxide produces a brown end product which is stable and can be
viewed by light microscopy.

The two-step indirect method of immunoenzymatic staining was used to
detect Fas receptor in tissue sections (see Figure 5). After incubation with the
unlabelled primary antibody (mouse anti-rat Fas monoclonal antibody), a horse
radish peroxidase-labelled secondary antibody directed against the primary
antibody was applied. As the primary antibody was produced in the mouse, the
secondary antibody chosen bound with mouse immunoglobulins. The section
was then incubated with DAB and hydrogen peroxide to produce the coloured
end product.

~

~

)~

KEY
Antigen

Primary Antibody

Enzyme Labelled
Secondary Antibody

FIGURE 5:

-

)~
~

r-

Two-Step Indirect Method of lmmunoenzymatic Staining

A labelled avidin-biotin technique was used to detect the presence of Fas ligand
(see Figure 6).

This method utilises the high affinity between avidin or

streptavidin and biotin. After the unlabelled primary antibody (goat anti-rat Fas
ligand polyclonal antibody) was applied, sections were incubated with the
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secondary antibody, which was biotinylated (covalently bound to biotin). As the
primary antibody was produced in the goat the secondary antibody chosen
bound with goat immunoglobulins.

Streptavidin labelled with horse rad ish

peroxidase was then applied to sections to bind with the biotin on the secondary
antibody, and DAB and hydrogen peroxide were applied to produce the
coloured end product.

KEY

~

r-

J~
FIGURE 6:

Antigen
Primary Antibody
Biotinylated Secondary
Antibody
Streptavidin Horse
Radish Peroxidase

)~
~

,f"T

'd

Labelled Avidin-Biotin Method of lmmunoenzymatic Staining.

The Fas antigen has previously been localised in the human ovary using
the avidin-biotin immunoperoxidase method (Kondo

et a/, 1996).

It is

necessary, however, to confirm the presence and localisation of both Fas
receptor and Fas ligand at the time of corpus luteum regression, as both are
required for induction of Fas-mediated apoptosis. Thus, the present study was
designed to examine patterns in staining of corpora lutea at the same stage of
pregnancy and post-partum, as well as at different stages. It was also planned
that a comparison of results for Fas receptor and Fas ligand would be made.
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4.2.

Sample and Tissue Preparation

For the study, four rats from each stage of pregnancy and post-partum
(i.e. days 1, 8, 16 and 22 of pregnancy and days 1 and 3 post-partum) were
required, and one ovary from each rat was used.

Portions of spleen were

excised from rats for use as positive controls. Following excision, the ovaries
and portions of spleen were fixed in 4% paraformaldehyde at 4'C for 24 hours.
They were then kept in phosphate buffered saline (PBS) at 4 'C until
processing.

Tissue was processed using a Shandon Citadel 1000 Tissue

Processor with a 10 hour protocol, as outlined in Table 2.

Table 2
10 Hour Protocol for Tissue Processing

SOLUTION
50% Ethanol
70% Ethanol
90% Ethanol
Absolute Ethanol
Absolute Ethanol
Absolute Ethanol
Slidebright
Slidebright
Paraffin Wax
Paraffin Wax

INCUBATION TIME
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour
1 hour

After being placed within wax in a vacuum embedder for 30 minutes, the
tissue was embedded in paraffin wax and stored at -20'C to allow the blocks to
harden. Sections with a thickness of 5 microns were cut using a microtome.
Four sections from each ovary, placed on separate slides, were required - one
for detection of Fas receptor, one for detection of Fas ligand and two for use as
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negative controls. A section of spleen was also placed on each of the slides for
use as a positive control. The slides were incubated at 45•c overnight to dry.

4.3.

Method

Paraffin wax was removed from the sections using toluene, and the
slides were then
concentrations.

rehydrated through alcohol solutions

of decreasing

The sections were incubated in 3% hydrogen peroxide in

methanol for 10 minutes and washed three times in fresh PBS.

When staining for Fas receptor, sections were first incubated in 1%
sodium dodecyl sulphate (SDS} for 5 minutes and then washed in fresh PBS
three times.

Sections were incubated with primary antibody (mouse anti-rat

Fas monoclonal lgG, 250pglmL} diluted 1 in 100 with PBS plus 1% bovine
serum albumin (BSA) at room temperature for 2 hours, then washed in fresh
PBS three times. The secondary antibody (sheep anti-mouse immunoglobulin,
0.5mg/mL), which was diluted 1 in 100 with PBS plus 1% BSA plus 2% normal
rat serum, was incubated on sections for 45 minutes.

The slides were then

washed in fresh PBS three times.

When staining for Fas ligand, sections were incubated with the primary
antibody (goat anti-rat Fas ligand polyclonallgG, 200pglmL) diluted 1 in 50 with
PBS plus 1% BSA at room temperature for 2 hours, then washed in fresh PBS
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three times. Sections were incubated with the secondary antibody (biotinylated
rabbit anti-goat lgG, 1.5mg/mL) diluted 1 in 50 with PBS plus 1% BSA plus 2%
normal rat serum for 45 minutes, then washed in fresh PBS three times.
Streptavidin horse radish peroxidase conjugate was diluted 1 in 50 with PBS
plus 1% BSA and incubated on sections for 45 minutes.

Slides were then

washed in fresh PBS three times.

Negative controls for each section were treated in the same manner, but
received diluent only in place of primary antibody.

Sections of spleen were

placed in each run as a positive control.

All

sections

were

then

incubated

for

10

minutes

with

3,3'diaminobenzidine tetrahydrochloride (DAB) solution and then washed in
fresh PBS three times.

Sections were counterstained by placing in

haematoxylin for 6 seconds, then dehydrated through alcohol solutions of
increasing concentrations and finally toluene. Slides were coverslipped using
DPX mountant for viewing by light microscopy.

See Figure 7 for experimental design. Detailed protocols are contained
in Appendix B.
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!

1 Fix 24hrs in 4% Buffered Paraformaldehyde at 4°C 1

!

1Store in PBS at 4°CJ
~

1Process Tissue and Paraffin Embed 1
~

1 Cut 5 micron Tissue Sections

-•-

Immunohistochemistry
1o Ab: Mouse anti~rat Fas mAb
2o Ab: Biotinylated rabbit anti-goat lgG

J

Immunohistochemistry
1o Ab: Goat anti~rat Fasl pAb
2o Ab: Sheep anti-mouse -HRP

3° Step: Streptavidin HRP

•

1 Chromogen: DAB J

+

1Counterstain: Haematoxylin 1

I
FIGURE 7:

.

•

Mountant: DPX

I

Experimental Design for Immunohistochemistry
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4.4.

Results

The presence of Fas receptor and Fas ligand within the rat corpus
luteum

during

pregnancy

and

post-partum

was

established

using

immunohistochemistry.

4.4.1. Fas Receptor

Initially, the manufacturer's recommended protocol was followed when
staining for Fas receptor.

The primary antibody was diluted 1 in 500 and

incubation times for primary and secondary antibodies were 30 minutes each.
Staining was not observed in any of the sections tested under these conditions.
Dilution of the primary antibody was reduced to 1 in 100 and incubation times
were increased to 60 minutes for the primary antibody and 45 minutes for the
secondary antibody. Very pale staining was seen with these conditions. The
primary antibody was then diluted 1 in 50, with incubation times remaining
unchanged.

These parameters resulted in some nonspecific staining of

negative control sections. The incubation time was increased to two hours and
the primary antibody was diluted 1 in 100 to alleviate nonspecific staining. Prior
to application of primary antibody the Fas antigen was further exposed with
treatment of 1% SDS for 5 minutes to improve stain.
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Pale immunohistochemical staining indicated that the Fas receptor was
present in the rat corpus luteum at day 1 of pregnancy. No stain was seen in
corpora lutea of rats at days 8 and 16 of pregnancy. Whilst pale staining was
present at day 22 of pregnancy, the stain was most intense in the corpus
luteum at day 1 post-partum. Staining was present, but less intense, at day 3
post-partum (see Figure 8).

Within the corpus luteum, staining was

concentrated in the cytoplasm of luteal cells.

Endothelial cells displayed no

positive staining for Fas receptor (see Figure 10). Negative control sections
showed no nonspecific staining. Positive control sections (spleen) displayed
scattered staining.

The staining pattern and intensity in the spleen was

consistent between immunohistochemical runs.

4.4.2. Fas ljggnQ

A 1 in 400 dilution of anti-rat Fas ligand polyclonal antibody with an
incubation time of 60 minutes was initially used to localise Fas ligand, however
no staining was seen with these conditions. Decreasing the dilution of primary
antibody to 1 in 100 resulted in very pale staining which was unconvincing. The
dilution of primary antibody was decreased further, to 1 in 50, but staining was
not improved. Increasing the incubation time of the primary antibody {diluted 1
in 50) to two hours was found to improve the staining intensity dramatically, so
this protocol was chosen for all sections.
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Fas ligand was present in the rat corpus luleum at all stages of
pregnancy and post-partum examined.

AI day 1 of pregnancy all but one

corpus luteum in each rat ovary stained intensely (see Figure 12). The staining
intensity decreased by day 8 and decreased further by day 16, with all corpora
lutea staining positively at these stages. Expression of Fas ligand increased in
corpora lutea at day 22 of pregnancy. Staining of Fas ligand was intense at
day 1 post-partum and had decreased by day 3 post-partum (see Figure 11).
Staining within the corpus luleum was seen in the cytoplasm of luteal cells.
Endothelial cells did not stain positively for Fas ligand (see Figure 14).
Nonspecific staining was not apparent in negative control sections.

A

characteristic scattered staining pattern was seen in the positive control
sections of the spleen. The intensity of staining in the spleen was consistent
between immunohistochemical runs.
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FIGURE 8.
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(h)

,1/11.

Rat ovary sections incubated with anti-Fas mAb and stained with DAB using
the immunoperoxidase method. Counterstained with haematoxylin. 40x. Stain
was present at day 1 of pregnancy, but not at days 8 and 16 of pregnancy.
Pale staining was present at day 22 of pregnancy. Intensity of stain was
highest at day 1 post-partum and was decreasing by day 3 post-partum. The
positive control showed scattered staining, while the negative control showed
no nonspecific staining. (a) Day 1 of Pregnancy. (b) Day 8 of Pregnancy. (c)
Day 16 of Pregnancy. (d) Day 22 of Pregnancy. (e) Day 1 Post-Partum. (f)
Day 3 Post-Partum. (g) Spleen, Positive Control. (h) Day 1 Post-Partum,
Negative Control. Arrows - Luteal Cells. Arrowheads - Endothelial Cells .
.•
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FIGURE 9.

Stain for Fas in corpus luteum was distinct compared to the
ovarian stroma and follicles . Rat ovary section incubated with
anti-Fas mAb and stained with DAB using the immunoperoxidase
method . Counterstained with haematoxylin . 10x. Day 1 PostPartum. CL - Corpus Luteum. S - Stroma. F - Follicle.

FIGURE 10. Stain for Fas within the corpus luteum was isolated to the
cytoplasm of luteal cells. Endothelial cells did not stain positively
for Fas receptor. Rat ovary section incubated with anti-Fas mAb
and stained with DAB using the immunoperoxidase method.
Counterstained with haematoxylin. 1OOx. Day 1 Post-Partum.
Arrows - Luteal Cells. Arrowheads - Endothelial Cells.
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FIGURE 11.

....

(d)

Rat ovary sections incubated with anti-Fas ligand polyclonal antibody and
stained with DAB using the immunoperoxidase method. Counterstained with
haematoxylin. 40x. Stain was present at all stages of pregnancy and postpartum. At day 1 of pregnancy all but one corpus luteum in each ovary stained
intensely. The staining intensity decreased in day 8 and again in day 16 (all
corpora lutea at these stages were stained), increasing at day 22 of pregnancy.
Staining at day 1 post-partum was at its most intense. At day 3 post-partum
the intensity of stain decreased slightly. The positive control showed scattered
staining, while the negative control showed no nonspecific staining. (a) Day 1
of Pregnancy. (b) Day 8 of Pregnancy. (c) Day 16 of Pregnancy. {d) Day 22 of
Pregnancy. (e) Day 1 Post-Partum. (f) Day 3 Post-Partum. (g) Spleen,
Postive Control. {h) Day 1 Post-Partum, Negative Control. Arrows - Luteal
Cells. Arrowheads - Endothelial Cells.
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FIGURE 12. At day 1 of pregnancy all but one corpus luteum in each rat ovary
stained positively for Fas ligand . Rat ovary section incubated with
anti-Fas ligand polyclonal antibody and stained with DAB using
the immunoperoxidase method. Counterstained with
haematoxylin. 1Ox. Day 1 of Pregnancy. CL - Corpus Luteum. S
- Stroma. F - Follicle.

CL

F

s

FIGURE 13. Whilst staining was observed in the ovarian stroma and some
follicles, the staining intensity was highest in corpora lutea at day
1 post-partum. Rat ovary section incubated with anti-Fas ligand
polyclonal antibody and stained with DAB using the
immunoperoxidase method. Counterstained with haematoxylin.
1Ox. Day 1 Post-Partum. CL- Corpus Luteum. S - Stroma. F Follicle.
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FIGURE 14. Within the corpus luteum, Fas ligand staining was observed within
the cytoplasm of luteal cells. Endothelial cells displayed no
positive staining for Fas ligand. Rat ovary section incubated with
anti-Fas ligand polyclonal antibody and stained with DAB using
the immunoperoxidase method. Counterstained with
haematoxylin . 100x. Day 1 Post-Partum. Arrows - Luteal Cells.
Arrowheads - Endothelial Cells.
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5.

RELATIVE QUANTITATIVE RT-PCR

5.1.

Rationale

Reverse transcription-polymerase chain reaction (RT-PCR) was used to
show the regulation of messenger RNA (mRNA) for Fas receptor and Fas
ligand during natural regression of the rat corpus luteum.

The expression of genes in cells or tissue is analysed by the detection of
mRNA, as only those genes expressed by the cell will be transcribed into RNA.
Sensitivity is an important consideration when choosing a method for the
detection of mRNA.

Procedures commonly used include Northern gels or in

situ hybridization. These protocols require species-specific probes which were
not available at the time of completion of this project.

Our laboratory has

recently cloned Fas and Fas ligand for rat ovaries. Thus, future studies utilising
Northern gels and in situ hybridization may be undertaken.

Use of the polymerase chain reaction to amplify complementary DNA
(eDNA) produced from mRNA, a method first described by Seaburg

et at in

1986 (cited in Kawasaki, 1990, pg. 21), provides a rapid method of detection of
mRNA with sensitivity comparable to in situ hybridization. This method, known
as RT-PCR, involves the extraction of RNA from cells or tissue, the generation
of eDNA by reverse transcription and amplification of eDNA by specific primers
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using PCR. The product can be viewed by fractionating the completed PCR
reaction on an ethidium-bromide stained agarose gel.

Alternatively, PCR

products which were radioactively labelled during the PCR reaction can be
fractionated on an agarose gel and quantitated using autoradiography or
phosphorimaging.

The first step required for RT-PCR is RNA isolation, which involves
separating RNA from other cellular contents, such as DNA and proteins.
Tissue samples are homogenized in a commercial preparation containing
guanidinium, such as RNAzol B. Chloroform is added to the homogenate and
the suspension is centrifuged.

RNA forms complexes wHh guanidinium and

water molecules, whilst DNA and proteins are removed from the aqueous
phase. The upper aqueous phase (containing RNA) is transferred to a new
tube while the lower phases, containing DNA and proteins in chloroform, are
discarded.

RNA is precipitated by the addition of isopropanol and then

centrifuged to form a pellet.

The RNA pellet is washed with 75% ethanol,

dessicated briefiy, resuspended in water and stored at -80'C.
concentration

and

purity

of

isolated

RNA

can

be

determined

The
by

spectrophotometric analysis.

Isolated RNA is used to generate eDNA in a reaction catalyzed by
reverse transcriptase. The reverse transcription reaction is initiated either with
random hexamers, a specific downstream primer, or oligonucleotide primers
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(oligo-dT).

Primers bind to mRNA and initiate transcription of the message.

Oligo-dT, for example, is a sequence of six thymidylates which bind to the poly
adenylate tails of mRNA (see Figure 15). A small amount of RNA is placed in a
PCR tube with water and primers and briefly heated at 70oC to unwind RNA. A
mixture of the following is then added:
• Reverse transcriptase, the enzyme which transcribes RNA into eDNA;
• RT buffer, a buffer supplied with reverse transcriptase;
• Deoxynucleotides (dNTPs), a mixture of the four nucleotides required for
transcription;
• Magnesium chloride (MgCI 2), which catalyzes the reverse transcriptase
reaction; and
• Rnasin, which breaks down any RNases present and thus prevents RNA
degradation.
The reactants are incubated at 42oC for 30-60 minutes to allow RNA to be
transcribed into eDNA (see Figure 15). The reaction is then heated to between
70°C and 95oC for 5 to 15 minutes in order to denature the RNA-eDNA hybrid
and to inactivate reverse transcriptase so that it will not interfere with future
PCR reactions. The temperature of the tube is quickly dropped to 4oC and the
reaction mix is stored at -20°C.
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mRNA
eDNA

s· - - - - - - AAAMA
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II II I I

(Oiigo-dT Primer)

FIGURE 15: Reverse Transcription of RNA into eDNA

The eDNA obtained from reverse transcription is amplified using PCR
technology. The following reagents are required for the PCR reaction:
• eDNA, containing the target message to be amplified;
• DNA polymerase, a heat-stable enzyme which replicates DNA;
• Polymerase buffer, manufacturer's buffer supplied with DNA polymerase;
• MgCI2 or Sodium Pyrophosphate, which catalyses the PCR reaction;
• dNTPs, a mixture of the four nucleotides required for amplification of DNA;
• Primers, specific primers synthesized from DNA sequences on either side of
the required message are added to excess and serve to iniliate the
amplification process;
• Distilled water, as required, to increase reaction volume and dilute reagents.
The reactants are heated to around 94 •c for a short period of time
(approximately 4-5 minutes) to ensure that the RNA-eDNA hybrid produced by
reverse transcription is denatured and cooled to approximately

ss•c to

allow

the synthesized primers to anneal to eDNA. Heating the reaction to about 72•c
facilitates replication of eDNA by DNA polymerase. The eDNA-DNA strand is
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then denatured by heating to approximately 94'C and the cycles of heating and
cooling are repeated to exponentially amplify the DNA.

Each cycle of the PCR reaction theoretically doubles the amount of DNA
produ~ed.

For example, after one cycle two DNA strands are present, after two

cycles four DNA strands are present, after three cycles eight DNA strands are
present, and so on. In practice, the actual amount of DNA amplified is less
than predicted as the efficiency of PCR reactions vary depending on the
conditions used. The number of heating and cooling cycles chosen may range
from 15 to 40 cycles, after taking into consideration such factors as the amount
of message initially used, the amount of message required for the PCR reaction
and the overall efficiency of the reaction. The concentrations of reagents and
the temperatures and incubation times for each of the steps may influence
reaction efficiency, therefore the PCR reaction conditions should be optimised
for each message to be amplified.

Depending on the initial amount of message, amplification usually runs
at a constant efficiency of about 70-80% between cycles 15 and 30 of the
reaction (Ferre, 1992). After a limited number of cycles the PCR reaction
reaches a plateau phase and thereafter the amplification efficiency begins to
decrease. Many factors, including a decrease in concentration of dNTPs or
primers, reaction inhibition by end-products, competition for reagents by
nonspecific products or primer-dimers, and incomplete denaturation of end-
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product, contribute to the plateau phase (Innis and Gelfand, 1990, pg. 10).
When quantitating without internal controls in PCR, it is important to stop the
reaction in the exponential phase, before the efficiency of the reaction becomes
variable and the chance of nonspecific products being preferentially amplified

increases.

In order to quantitate the amount of DNA produced in each PCR
reaction, a radioactively labelled nucleotide (a32 P-dCTP) can be added to the
reaction. The nucleotide is incorporated into DNA as it is synthesized and the
radioactivity of the amplified product is quantitated.
quantitation were used in the present study.

Two methods of

lri the first, unincorporated

nucleotides were removed using isopropanol extraction and counts per minute
of the sample obtained from a liquid scintillation counter. In the second, each
sample was fractionated on an agarose gel (unincorporated nucleotides,
weighing less than DNA, travel further along the gel) which was dried and
exposed to a phosphorimaging plate. The resultant image produced by the
radioactivity of the samples was quantitated using a computer image analysis
program.

The first step in making relative comparisons between the amount of
message expressed in the rat at various stages of pregnancy and post-partum
involved identifying a dilution factor for each time-point at which the PCR
reaction was amplifying exponentially. Following reverse transcription, four-fold
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serial dilutions of one sample from each time-point were amplified by PCR for a
set number of cycles.

The samples were then quantitated and the results

plotted on a logarithmic graph (see Figure 16). .
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FIGURE 16: Decreasing Dilutions of eDNA Plotted on a Logarithmic Scale
Following Amplification by PCR.

A dilution factor for each time-point was chosen where the PCR reaction
would be amplifying exponentially when stopped.

All samples were then

amplified at the specified dilution in one PCR run. The amounts of message
expressed at the time-points were compared relative to each other by allowing
for the dilution factor used for the eDNA.

Fas mRNA expression has been demonstrated in human granulosa I
luteal cells using RT-PCR techniques (Quirk et a/, 1995), but the expression of
Fas ligand mRNA in these cells has yet to be confirmed. The relative amounts
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of message expressed at various stages of pregnancy and post-partum in the
rat ovary has not previously been investigated.

This information may thus

assist in providing an insight into the function of the Fas/Fas ligand system in
the rat ovary.

5.2.

Sample and Tissue Preparation

The animals used for this study were:- four rats from days 1, 8 and 16 of
pregnancy and day 3 post-partum, five rats from day 22 of pregnancy and eight
rats from day 1 post-partum.

The right ovary from each rat was dissected.

Immediately following excision each ovary was snap frozen in liquid nitrogen
and stored at -sooc until use.

5.3.

RNA Isolation.

Method

Whole frozen ovaries were homogenised in

1300~L

RNAzol B. 130~L of chloroform was added and mixed and the samples were
incubated on ice for 5 minutes. The mixtures were centrifuged at 14,000rpm for
15 minutes. Equal volumes of isopropanol were added and mixed, and tubes
were incubated at 4°C for one hour.

The mixtures were centrifuged at

14,000rpm for 15 minutes and the supernatants were decanted. After adding
1mL 75% cold ethanol, the tubes were vortexed and centrifuged at 6,000rpm
for 8 minutes. The supernatants were decanted and dessicated in a biohazard
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cabinet for 15 minutes.
DMDC-treated water.

The resulting pellets were resuspended in 10)lL of
The quantity and purity of the isolated RNA was

determined using a Beckman DU-640 Spectrophotometer.

Relative Quantitative RT-PCR for Fas Receptor. Reverse transcription
was performed by adding 2)lL oligo-dT primer (500ng/)lL), 2)lg sample RNA
and DMDC-treated water to a total volume of 10)lL
contained DMDC-treated water in place of RNA.

Negative controls

The reaction mixes were

heated to 70oC for 5 minutes and then placed on ice. A master mix of reagents
containing 5)lL reverse transcriptase buffer (5x), 5)lL dNTPs (5mM), RNasin
(40Ui)lL), sodium pyrophosphate (40mM) and AMV reverse transcriptase
(23Ui)lL) was added to each tube. The reaction mixes were placed in a thermal
cycler and incubated at 42oC for 60 minutes, heated to 95°C for 5 minutes and
then cooled to 4°C. The eDNA was stored at -20°C.

PCR for Fas receptor was performed by adding a master mix of reagents
to 5)lL eDNA. Negative controls contained DMDC-treated water in place of
eDNA The master mix contained 11 .35)lL DMDC-treated water, 2.5)lL Taq.
polymerase buffer (10x), 4.0)lL MgCI, (25mM), 0.1)lL dATP (100mM), 0.1)lL
dTTP (100mM), 0. 1)lL dGTP (100mM), 0.025)lL dCTP (100mM), 0.075)lL a 32 PdCTP (300mM), 1.5)lL Fas primers (2pmoli)lL, Upstream Sequence: 5' CTG
CAG ATA TGC TGT GGA TCA 3', Downstream Sequence: 5' TTT GGT GTT
GCT GGT TGG T 3') and 0.25)lL Taq polymerase per reaction. Reaction mixes
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were placed in a thermal cycler and heal'd to 94'C for 4 minutes 30 seconds.
The tubes were then incubated at 94'C for 30 seconds, 58'C for 45 seconds
and 72'C for 1 minute and this cycle was repeated 35 times. The amplified
samples were incubated at 72'C for 5 minutes, cooled to 4'C and stored at20'C.

PCR products were fractionated on an ethidium bromide stained agarose
gel, dried on a slab gel dryer and either exposed to x-ray film or a
phosphorimaging plate overnight. Quantttation was performed using an image
analysis program. Initially, four-fold serial dilutions (i.e. neat,

1
1
1
/ 4 , / 16 , / 64)

of one

sample from each lime-point were amplified by PCR, quantitated and the
results plotted on a logarithmic graph. A dilution in the exponential phase of the
PCR reaction was chosen for each lime-point. One PCR run with all eDNA
samples at the specified dilution was completed and quantitated. Data from
different time-points were compared after allowing for the dilution factor used in
the PCR reaction.

Relative Quantitative RT-PCR for Fas ligand. Reverse transcription was
performed by adding

2.5~L

of 3'-end primers for Fas ligand

Sequence: 5' AGT CTC TAG CIT ATC CAT GA 3'),

t~g

DMDC-treated water to make up the volume to 9~L.

(5pmoii~L.

sample RNA and
Negative controls

contained DMDC-treated water in place of RNA. . Solutions were heated to
70'C for 5 minutes.

A master mix of reagents containing

5~L

reverse
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transcriptase buffer (5x), 611L dNTPs (5mM), 111L RNasin (40U/IlL), 2.51lL
sodium pyrophosphate (40mM) and 2.51lL AMV reverse transcriptase (23U/IlL)
was added to each tube. Reaction mixes were placed in a thermal cycler and
incubated at 42'C for 60 minutes, heated to 95'C for 2 minutes, then cooled to
4'C. The eDNA was stored at -20'C.

PCR for Fas ligand was performed by adding a master mix of reagents
to Z11L eDNA.
eDNA.

Negative controls contained DMDC-treated water in place of

The master mix contained 14.351lL DMDC-treated water, 2.51lL

PLATINUM™ Taq polymerase buffer (10x), 2.51lL MgCI, (25mM), 0.111L dATP
(100mM), 0.1 11 L dTIP (100mM), 0.111L dGTP (100mM), 0.0251lL dCTP
(100mM), 0.0751lL o:"P-dCTP (300mM), 3.01lL Fas ligand primers (2pmollllL,
Upstream Sequence: 5' AAA GAG GAG AAG GTC CAA CA 3', Downstream
Sequence: 5' AGT CTC TAG CIT ATC CAT GA 3') and 0.2611L PLATINUM'"
Taq polymerase (5.5UillL) per reaction. The reaction mixes were placed in a
thermal cycler and heated to 94'C for 4 minutes 30 seconds. The tubes were
then incubated at 94'C for 30 seconds, 58'C for 1 minute and 72'C for 1
minute, and this cycle was repeated 32 times. The amplified samples were
incubated at 72'C for 5 minutes, cooled to 4'C and stored at -20'C.

Isopropanol extraction was used to remove unincorporated nucleotides
from PCR products. One tenth volume of sodium acetate, pH 5.2, an equal
volume of isopropanol and 111L glycogen were added to each tube.

The
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solutions were mixed, incubated at 4•c for 15 minutes and centrifuged at
14,000rpm for 15 minutes.

The supernatant was removed and the pellet

washed with 500pL 70% cold ethanol and then vortexed. The samples were
centrifuged at 14,000rpm for 5 minutes, the supernatant removed and the
samples dessicated for 10-15 minutes in a biohazard cabinet. The pellets were
resuspended in 15pL ddH,O and quantitated with a liquid scintillation counter.
Initially, four-fold serial dilutions (i.e. neat, '14 , '1,., '1.,, '1,,.) of one sample from
each time-point were amplified by PCR, quantitated and the results plotted on a
logarithmic graph. A dilution in the exponential phase of the PCR reaction was
chosen for each time-point.

One PCR run with all eDNA samples at the

specified dilution was completed and quantitated.

Data from different time-

points were compared after allowing for the dilution factor used in the PCR
reaction.

See Figure 17 for experimental design. Detailed protocols are contained
in Appendix B.
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FIGURE 17: Experimental Design for Relative Quantitative RT-PCR.
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5.4.

Results

Expression of Fas receptor and Fas ligand mRNA in the rat ovary during
pregnancy and post-partum was analysed using a relative quantitative method
of RT-PCR.

5.4.1. Confirmation of mRNA Expression

Expression of mRNA for Fas receptor and Fas ligand at the various
stages of pregnancy and post-partum examined was confirmed by amplifying
eDNA of one sample from each time-point by PCR. The PCR product was run
on an ethidium-bromide stained agarose gel and viewed under UV light. Both
Fas receptor and Fas ligand mRNA were expressed at all stages examined
(see Figures 18 and 19 respectively).
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491 bp

Lane 1: Day 1 of Pregnancy
Lane 2: Day 8 of Pregnancy
Lane 3: Day 16 of Pregnancy
Lane 4: Day 22 of Pregnancy
Lane 5: Day 1 Post-Partum
Lane 6: Day 3 Post-Partum
Lane 7: PCR -ve Control
Lane 8: PCR +ve Control 1 9
Lane 9: 1kb Standard Markers

o·

FIGURE 18: Ethidium Bromide Stained Agarose Gel from Fas Receptor RTPCR. Fas mRNA is expressed at each of the stages of
pregnancy and post-partum examined. NOTE: 1.5pl of dNTPs
(5mM) per reaction were used; a 32 P-dCTP was not included;
Samples were amplified over 38 cycles.
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._ 341 bp

Lane 1: Day 1 of Pregnancy
Lane 2: Day 8 of Pregnancy
Lane 3: Day 16 of Pregnancy
Lane 4: Day 22 of Pregnancy
Lane 5: Day 1 Post-Partum
Lane 6: Day 3 Post-Partum
Lane 7: RT -ve Control
Lane 8: PCR -ve Control
Lane 9: PCR +ve Control 1o-8
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FIGURE 19: Ethidium Bromide Stained Agarose Gel from Fas Ligand RT-PCR.
Fas ligand mRNA was expressed at each of the stages of
pregnancy and post-partum examined. NOTE: 1.25pl of dNTPs
(5mM) per reaction were used; a 32 P-dCTP was not included; 1pl
of eDNA per sample was amplified; Samples were amplified over
35 cycles_

5.4.2. Optimal Activity of Radionucleotide in PCR

Samples of eDNA from day 8 of pregnancy and day 1 post-partum were
amplified by Fas ligand PCR with varying activities of a 32P-dCTP to determine
the optimal activity of radionucleotide to be used in future PCR reactions. The
activities tested were OpCi, 0.1pCi, 0.25pCi, 0.5pCi and 1pCi per reaction .
Unincorporated nucleotides were removed from the PCR products using
isopropanol extraction and counts per minute obtained with a liquid scintillation
counter. The results were plotted on a logarithmic graph (see Figure 20). An
activity of 0.75pCi (0.075pl) was used in future PCR reactions.
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FIGURE 20: PCR using Fas Ligand Primers with Varying Activities of a 32PdCTP per Reaction. Results at OpCi and 0.1 pCi were less than
that of negative control and thus are not shown.

5.4.3. Number of Cycles in Fas PCR

To ensure that samples would not be overamplified, four-fold serial
dilutions of one sample from day 16 of pregnancy and one sample from day 1
post-partum were amplified by Fas PCR either for 35 or 38 cycles. The PCR
products were run on an agarose gel to remove unincorporated nucleotides,
exposed to a phosphorimaging plate overnight, and quantitiated using the NIH
image analysis program. The results were plotted on logarithmic graphs (see
Figure 21 ). Amplification by 35 cycles was used for future Fas PCR reactions
as the results did not show a plateau phase. At 38 cycles the reaction efficiency
appeared to be slower and a plateau phase was evident, indicating
overam plification.
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FIGURE 21 : Fas PCR Using Varying Sample Dilutions Amplified by either:
(a) 35 cycles, or (b) 38 cycles.

5.4.4. Dilution Factors for Fas Receptor

A dilution factor for each time-point was chosen where the PCR reaction
would be amplifying exponentially when stopped. This was done by making
four-fold serial dilutions of one sample from each time-point and amplifying by
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PCR using Fas primers. PCR products were run on an agarose gel to remove
unincorporated nucleotides, exposed to a phosphorimaging plate overnight,
and quantitated using the NIH image analysis program.

The results were

plotted on a logarithmic graph (refer to Figure 21 (a) for an example).

All

samples were amplifying exponenthlly after 35 cycles at a dilution of 1 in 4,
except for day 22 of pregnancy, which was amplifying exponentially at a dilution
of1in16.

5.4.5. Relative Quantitative RT-PCR for Fas Receptor

RNA samples were reverse transcribed in one run using oligo-dT
primers. eDNA was diluted by the specified factor, and amplified by Fas PCR.
Unincorporated nucleotides were removed by running PCR products on an
agarose gel. The gel was dried and exposed to a phosphorimaging screen
overnight.

Samples were to be quantitated using the NIH image analysis

program, however the quality of the phosphorimage produced was not
adequate for quantitation. The experiment could not be repeated due to time
constraints.

5.4.6. Dilution Factors for Fas Ligand

A dilution factor for each time-point was chosen where the PCR reaction
would be amplifying exponentially when stopped. This was done by making
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four-fold serial dilutions of one sample from each time-point and amplifying by
PCR using Fas ligand primers.

Isopropanol extraction was used to remove

unincorporated nucleotides from PCR products and counts per minute were
obtained with a liquid scintillation counter.

The results were plotted on a

logarithmic graph (for example see Figure 22). Samples at day 1, 8 and 16 of
pregnancy were amplifying exponentially when not diluted (i.e. neat), whilst
samples at day 22 of pregnancy and day 1 and 3 post-partum were amplifying
exponentially at a dilution of 1 in 4.

1/128

1/16

Neat

Sample Dilution

FIGURE 22: Fas Ligand PCR at Day 1 Post-Partum Using Varying Sample
Dilutions to Determine Exponential Phase of Reaction.

5.4.7. Relative Quantitative RT-PCR for Fas Ligand

All RNA samples were reverse transcribed using 3'-end Fas ligand
pri mers. eDNA was diluted if required, then amplified by Fas ligand PCR.
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Unincorporated nucleotides were removed by isopropanol extraction and PCR
products were quantitated by obtaining counts per minute from a liquid
scintillation counter.

The results were averaged for each of the time-points

examined, and plotted as the fold change versus the average of day 1 of
pregnancy (see Figure 23).
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6.

IN VITRO CORPUS LUTEUM CULTURE MODEL

6.1.

Rationale

The discovery that spontaneous apoptosis occurs in rabbit corpora lutea
cultured in serum-free medium led to the development of an in vitro corpus
luteum culture model (Dharmarajan eta/, 1994). Corpora /utea functioning at
peak levels are dissected from the ovary and cultured in serum-free medium.
Treatments added can be assessed on the basis of their ability to reduce the
occurrence of spontaneous apoptosis.

Sridaran et a/ (1997) recently

demonstrated that rat corpora /utea are also capable of undergoing
spontaneous apoptosis when cultured in serum-free medium.

Quantitation of cell death by apoptosis was determined by 3'-end
/abe/ling of fragmented DNA.

The DNA is extracted from samples with

chloroform and isoamy/a/cohol.

The 3'-ends of fragmented DNA are then

labelled with radioactive u"P-ddATP in a reaction catalysed by terminal
transferase.

The

reactinn

is

terminated

with

the

addition

of

ethy/enediaminetetraacetic acid (EDTA), and labelled DNA is extracted from
unincorporated nuc/eotides by precipitation with ammonium acetate and
ethanol. The labelled DNA is fractionated on an agarose gel which is then
exposed overnight to X-ray film to produce an autoradiograph.

DNA

fragmented at multiples of 180 base pair fragments, as occurs in apoptosis, will
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show ladders in multiples of 180 base pairs on the gel, while DNA fragmented
randomly, as occurs in necrosis, will show a smear on the gel (Tilly and Hsueh,
1993). Low molecular weight DNA bands from each lane in the agarose gel are
excised and counts per minute measured in a liquid scintillation counter.

While some anti-Fas monoclonal antibodies are able to induce apoptosis
when bound to Fas receptor (Yonehara eta/, 1989; Trauth et at, 1989), others
are capable of blocking the receptor site and preventing transduction of an
apoptotic signal (Oshimi eta/, 1996). In this experiment, rat corpora lutea were
cultured in vitro in the presence of an anti-rat Fas monoclonal antibody, to
determine if spontaneous apoptosis could be blocked via the Fas/Fas ligand
system in luteal cells.

Apoptosis can be induced in cultured human granulosa I luteal cells
pretreated with interferon gamma when exposed to an anti-human Fas
monoclonal antibody (Quirk eta/, 1995), but studies aiming to block the function
of the Fas receptor in luteal cells have not previously been documented.

6.2.

Sample and Tissue Preparation

Four rats from day 16 of pregnancy were required. The ovaries were
excised and corpora lutea dissected from ovarian stroma. Two corpora /utea
were placed in each sterile culture vial. Five vials contained 2mL of serum-free
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medium only, five vials also contained

40~L

antibody storage buffer (50%

glycerol, 20mM NaH 2P04 pH 7.5, 1.5mM NaN,, 1mg/ml BSA) and five vials
also contained 40)ll anti-rat Fas monoclonal antibody (250)lg/ml).

6.3.

Method

Sterile culture vials were gassed with a 95% 0 2
lids sealed with vacuum grease and the vials incubated
CO, for 4 hours.

-

5% C02 mixture, their

at 37"C in 95% 0 2 -

5%

Corpora lutea were placed in sterile polypropylene tubes,

snap frozen in liquid nitrogen and stored at -BO'C.

To extract DNA, each sample (consisting of two corpora lutea) was first
homogenised in 670)ll of DNA homogenisation buffer and 42)ll 10% SDS was
added and mixed. The tubes were incubated at 65'C for 30 minutes, then
119)ll SM potassium acetate was added and mixed. The tubes were placed on
ice for 60 minutes and then microcentrifuged at 5,000rpm for 10 minutes. The
supernatant was transferred to a new tube, equal volumes of phenol:
chloroform:isoamyl alcohol (25:24:1) were added and the tubes vortexed. The
samples were then microcentrifuged at 6,000rpm for

5 minutes, the upper

phase

volumes

was

transferred

to

a

new tube,

equal

of phenol:

chloroform:isoamyl alcohol (25:24:1) were added and solutionE vortexed. The
tubes were again microcentrifuged at 6,000rpm for 5 minutes, the upper phase
was transferred to a new tube, 2.5x volume of cold 100% ethanol was added
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and the reaction mix stored overnight at -80'C.

The samples were

microcentrifuged at 14,000rpm for 30 minutes and the supernatants decanted.
The pellet was resuspended in 1OO~L TE, pH 8.0,

2~L

RNase was added and

the solutions were vortexed, briefly microcentrifuged and then incubated at
37'C for 60 minutes. The extraction with phenol:chloroform:isoamyl alcohol
(25:24:1) was repeated twice and the upper phases transferred to new tubes.
0.1x volume 3M sodium acetate and 2.5x volume cold 100% ethanol were
added

and

the

samples

stored

overnight at -80'C.

Tubes

were

microcentrifuged at 14,000rpm for 30 minutes and the supernatants decanted.
100~L

cold 100% ethanol was added, tubes >•ere placed on ice for 5 minutes

and then microcentrifuged at 14,000rpm for 5 minutes. The ethanol layer was
decanted and the pellets air dried over a paper towel for 1-2 hours before
resuspension in

50~L

ddH20. The quantity and purity of the isolated DNA was

established using a Beckman DU-640 Spectrophotometer, and the samples
stored at -80'C.

3'-end labelling was conducted on 1~g of DNA from each sample. A
sample of DNA from rat corpora Jutea, immediately snap frozen after dissection
from the ovary (time zero), was included as a baseline measurement against
which all samples would be compared. The volumes in each tube were made
up to 29~L with ddH,O. 10~L of terminal transferase reaction buffer (5x) and
5~L

CoCI2 were added, the tubes were vortexed and then microcentrifuged

briefly. a"P-ddATP (3,000Ci/mmol) was diluted 1 in 8 and 5~L was added to
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each tube. Terminal transferase was diluted 1 in 2 and l11l was added to each
tube. The samples were vortexed, microcentrifuged briefly and incubated at
37'C for 60 minutes.

S11l 0.25M EDTA, 211L !RNA, 1211L 10M ammonium

acetate and 18011l cold 100% ethanol were added and the tubes maintained at

-BO'C for 60 minutes. The samples were microcentrifuged at 14,000rpm for 20
minutes and supernatant was discarded. The pellet was resuspended in 6011l
of 1 x TE, 121ll10M ammonium acetate and 18011l of cold 100% ethanol were
added, the tubes vortexed and then placed at -BO'C for 60 minutes.

The

samples were microcentrifuged at 14,000rpm for 20 minutes, the supernatant
was discarded and the pellet was air dried over a paper towel for 20 minutes.
The pellet was resuspended in 401ll1x TE and stored at -20'C overnight.

The samples were thawed for 20 minutes and then electrophoresed for 2
hours 30 minutes on an agarose gel. The gel was dried on a slab gel dryer and
exposed to X-ray film overnight.

The film was developed and viewed for

evidence of the laddering of low molecular weight DNA.

Using the

autoradiograph as a template, low molecular weight DNA from each lane was
excised and quantitated using a liquid scintillation counter.

See Figure 24 for experimental design. Detailed protocols are contained
in Appendix B.

80

14 Rats at Day 16 of Pregnancy J
~

IExcise Ovaries and Dissect Corpora Lutea (CL) 1

+

+

4 Vials, 2 CUvial
Serum-Free Medium
+ anti-rat Fas mAb

+

5 Vials, 2 CUvial
Serum-Free Medium
Only

5 Vials, 2 CUvial
Serum-Free Medium
+ Ab Storage Buffer

r

•

4 Hour Organ Culture at arc

I

~
( Snap Freeze CL

•
•
•

1Extract DNA 1

f 3'-End Labelling
Quantitate Low Molecular Weight DNA
Using Liquid Scintillation Counter

FIGURE 24. Experimental Design for In Vitro Corpus Luteum Culture Model.
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6.4.

Results

6.4.1. 3'-End Labelling

3'-Ends of extracted DNA were radioactively labelled and DNA was
fractionated on an agarose gel. Laddering of low molecular weight DNA due to
cleavage into 180 base pair fragments, characteristic of apoptosis, was
identified (see Figure 25). Low molecular weight DNA was excised from each
lane of gel and quantitated with a liquid scintillation counter (see Figure 26).
Treatment with the antibody storage buffer demonstrated a trend in reduction in
occurrence of spontaneous apoptosis in cultured corpora lutea.

A further

reduction in apoptosis was apparent when corpora lutea were treated with an
anti-rat Fas monoclonal antibody in culture.
variable and no significance was found.

The results, however, were
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1

2

3

4

Lane 1

Time zero, snap frozen corpora
lutea
Corpora lutea cultured with
serum-free medium only
Corpora lutea cultured with
antibody storage buffer
Corpora lutea cultured with antirat Fas mAb

Lane 2
Lane 3
Lane 4

FIGURE 25: Autoradiograph of 3'-End Labelled DNA Extracted from Corpora
Lutea Cultured In Vitro with Varying Treatments
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7.

DISCUSSION

Previous research has indicated that the Fas/Fas ligand system may
have a role in regression of the corpus luteum (Watanabe-Fukunaga et a/,
1992; Quirk eta!, 1995; Kondo eta/, 1996). This study examined the regulation
of Fas receptor and Fas ligand in the rat corpus luteum during pregnancy and
post-partum to further confirm this hypothesis.

Immunohistochemistry was

used to localise both proteins at each of the stages examined. Regulation of
mRNA for Fas and Fas ligand was compared between stages with a relative
quantitative method of RT-PCR. The ability of an anti-Fas monoclonal antibody
to block the occurrence of spontaneous apoptosis in corpora lutea cultured

in

vitro with serum-free medium was also assessed.

Whilst immunohistochemistry can be used as a quantitative technique,
the evaluation of staining intensity can be subjective, particularly because
staining intensity may vary between cells in any one section. Also, the results
from different runs should not be directly compared as many factors, such as
incubation time and ambient temperature, may affect the intensity of the stain.
Immunohistochemistry is most effective when used to confirm the presence or
absence of a protein and differences in staining intensity between samples in a
single run. The variations which may be seen from run to run were countered
by including positive controls of a tissue known to express the protein in
question, in this case spleen. These sections were taken from a single tissue
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block.

The intensity and pattern of staining in positive control slides was

compared to evaluate if run to run differences were of concern.

In immunohistochemistry, it is not sufficient that the antigen under
investigation is present in the tissue being tested - the epitope to which the
antibody binds must be exposed for successful staining. Although the aim of
fixation is to maintain the original structure of the·tissue, changes do occur
during the fixation process, sometimes resulting in epitopes being concealed.
Exposure of epitopes may be facilitated by treating the sections with agents
such as detergents or the application of heat before the primary antibody is
applied. For example, sections were treated with 1% SDS to expose the Fas
antigen before treatment with the primary antibody.

Background staining in sections is a common problem encountered
when using immunohistochemical techniques.

There are many possible

causes for background staining, including endogenous enzyme activity,
endogenous biotin activity, and hydrophobic or ionic binding of antibodies. A
negative control of the same tissue treated in an identical manner except for
application of the primary antibody (diluent only is applied) should be run for
each section tested.

Staining on the negative control section should be

compared to that on the tissue section tested, to determine the degree of
background staining. Appropriate steps can be taken to reduce the amount of
background staining.

For example, endogenous peroxidase activity can be
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quenched by incubating the sections in 3% hydrogen peroxide diluted in
methanol before application of the primary antibody. This step was used when
staining for both Fas receptor and Fas ligand. Background staining did not
present a problem in either case.

When the Fas receptor is expressed on the cell surface it can be bound
and will then transduce an apoptotic signal to the cell. Thus, it is expected that
if the Fas/Fas ligand system is involved in cell death occurring during corpus
luteum regression, the presence of both proteins would correlate with
luteolysis. Fas receptor was localised in the rat corpus luteum at day 1 of
pregnancy and days 1 and 3 post-partum. Fas ligand was present in the rat
corpus

luteum

immunohistochemical
parturition.

throughout

pregnancy

and

post-partum,

with

staining intensity increasing around the time of

Thus, localisation of both proteins within the rat corpus luteum

during luteolysis was demonstrated.

The staining of Fas receptor observed at day 1 of pregnancy may relate
to natural regression of corpora lutea during the normal estrus cycle of the rat.
After formation and growth, rat corpora lutea maintain their maximum size
through metestrus of the following cycle and then regress slowly, so that three
or more generations of corpora lutea may be seen in the ovary (Hilliard, 1973).
Throughout pregnancy rat corpora lutea of previous cycles grow and display
characteristics of steroidogenic tissue (Bruce

e• a/,

1984). This indicates that

even following the onset of luteolysis, regression can be halted and corpora
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lutea may be functional. Fas receptor is not present in the corpora lutea of
previous estrus cycles at times of peak function in the corpus luteum of
pregnancy. This suggests that the factor which maintains the newly formed
corpus luteum in the rat may also positively affect the functioning of aged
corpora lutea. Also noteworthy is the finding that Fas ligand was present in all
but one corpus luteum in each rat ovary at day 1 of pregnancy.

Further

research will be required to ascertain if those corpora lutea which did not stain
for the presence of Fas ligand were newly formed.

Whilst progesterone production in the rat declines by day 22 of
pregnancy (Waddell

et a/,

1989), the weight of the corpora lutea of pregnancy

does not fall until after parturition (Bruce

et

a/, 1984; Taya and Greenwald,

1982). Fas receptor was present in corpora lutea at day 22 of pregnancy, with
staining intensity increasing by day 1 post-partum. Thus, it is not clear if the
Fas/Fas ligand system is involved in functional regression of the corpus luteum,
but a role in structural regression is implicated.

The weight of the corpus

luteum of pregnancy continues to decline over numerous estrus cycles
following parturition (Taya and Greenwald, 1982).. Staining intensity for both
Fas receptor and Fas ligand decreased by day 3 post-partum, although both
proteins were still present.

Further research will be required to determine

whether Fas receptor and Fas ligand are present in the rat corpus Juteum
throughout lactation.
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Previous research found no evidence of vascular degeneration during
natural regression of the pregnant rat corpus luteum (Bruce el a/, 1984). In
agreement with this report, both Fas and Fas ligand were localised in the
cytoplasm of luteal cells at the time of luteolysis, but staining was not observed
in endothelial cells at any stage of pregnancy or post-partum.

The presence of Fas ligand in rat corpora lutea throughout pregnancy
and post-partum indicates that luteal regression may not be its only function.
Fas ligand contributes to the immune privilege displayed by the Sertoli cells of
the mouse testis (Bellgrau et a/, 1995) and by the mouse eye (Griffith el a/,
1995).

The ovary has also been identified as an immune privileged site

(Streilein, 1995) and it is possible that Fas ligand has a role to play.
Furthermore, maintenance of corpora lutea may involve mechanisms of
immune privilege.

Luteal tissue is not present at the time that the immune

system is adapting to "self' (Bukovsky eta/, 1995) and it may be susceptible to
immune attack. Research using gld mice (which express non-functional Fas
ligand) is required to establish a role for Fas ligand-mediated immune privilege
in the ovary.

The expression of mRNA for both Fas and Fas ligand in the rat ovary
was compared at different stages of pregnancy and post-partum using a
relative quantitative method of RT-PCR. RT-PCR is a rapid technique and it is
also extremely sensitive. Thus mistakes at any of the steps in the protocol can
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produce significant errors in the final results. Further, any error will be amplified
during the PCR step. For these reasons samples must be treated under the
same conditions at all times anr!, if possible, be processed in a single run in
order to reduce between-batch variability.

A master mix of reagents is

dispensed into each tube for reverse transcription and PCR reactions, so the
concentration of reactants in each of the tubes is the same.

One of the advantages of relative quantitative RT-PCR is that the
synthesis of internal controls (a time-consuming exercise) is not necessary.
However, as reverse transcription and coamplification of samples with
exogenous internal controls is not undertaken with this method the possibility of
varying reaction efficiencies due to well-to-wel/ variations in the thermal cycler is
not controlled. To ensure that allowance was made for variability, at least four
samples from each time-point were used and the results were averaged.
Standard errors obtained for Fas ligand indicated that the results were
reproducible.

Another influence on reaction efficiency is the amount of message in the
PCR tube. By making serial dilutions of one sample from each time-point to
identify the exponential phase of the reaction, and then using that dilution factor
for the final PCR, the amount of message in each tube is similar. Multiplying
the result by the dilution factor used permits relative comparisons between
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samples.

The sample size (at least four for each time-point) assists in

accounting for variations In reaction efficiency as results are averaged.

Formation of primer-dimers in PCR reactions can create difficulties when
quantitating results.

High counts in negative controls were initially obtained

from Fas ligand PCRs, indicating that primer-dimers were being formed. The
occurrence of primer-dimers can be reduced by developing primers with less
complementary sequences, using a hot start PCR method or using a Taq
polymerase which is not activated until heated.

The development of new

primers was beyond the scope and time limitations of this project. Hot start
PCRs, which involve adding an essential reagent to each sample tube only
after the reactants have been heated to 94 'C (Ferre, 1992), was not a preferrecl
solution in this case, given that exposure to radioactivity would be increased
and the risk of contaminating samples is high. Thus, a Taq Polymerase which
is not activated until heated was used to reduce primer-dimers. PLATINUM'"
Taq DNA Polymerase, supplied by Gibco BRL, is bound to an antibody which
inhibits polymerase activity.

The enzyme regains activity during the

denaturation step at 94'C, providing an automatic hot start without the risk of
sample contamination and ensuring that all samples receive the same amount
of reactants.

Use of this enzyme in Fas ligand PCR reduced the counts

obtained in negative controls, indicating a reduction in primer-dlmer formation.
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Although dilution factors for each of the time-points of the Fas PCR were
determined by quantitating from an agarose gel using a phosphorimage, results
for the final PCR run with all samples could not be obtained. The quality of the
phosphorimage produced was not adequate for quantitation. It is likely that
formation of primer-dimers influenced PCR reaction efficiency as preparation
time was increased in the final run due to the high number of samples. Also,
consistency in image quality appeared to vary across the phosphorimage,
making accurate quantitation difficult. Time constraints precluded repeating
the Fas PCR. My next step will be to repeat the PCR using PLATINUMTM Taq
Polymerase to reduce primer-dimer formation. Quantitation will be effected by
counts

per minute following

isopropanol extraction of unincorporated

nucleotides, as this method of quantitation was effective for the Fas ligand PCR
(as shown in Figure 23).

The expression of Fas ligand mRNA in the rat ovary decreased slightly
from day 1 to day 16 of pregnancy. A significant increase in expression was
observed from day 16 to day 22 of pregnancy, just prior to parturition. This
increase is consistent with the immunohistochemical findings and coincides
with luteolysis.

Expression appeared to decrease at day 1 post-partum,

however the results were not significantly different from those at day 22 of
pregnancy. The decrease in expression from day 22 of pregnancy to day 3
post-partum was significant.

In summary, Fas ligand mRNA expression
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increases significantly at the time of luteolysis and regulation appears to follow
a similar pattern to that seen in localisation of the protein.

An in vitro corpus luteum culture model was used to evaluate the
ability of an anti-Fas monoclonal antibody to block spontaneous apoptosis in
corpora lutea placed in serum-free medium.

This model does not allow

identification of the proportion of cells undergoing apoptosis due to the loss of
contact with surrounding cells, which may be caused by the trauma of
dissection from the ovary. Care was taken when dissecting corpora lutea from
the ovary and all samples were treated in the same way to reduce injury to
cells.

The monoclonal antibody chosen for this study was stored in a
buffer containing 50% glycerol, a small percentage of BSA, monosodium
phosphate and sodium azide. As the storage buffer may have influenced the
apoptosis of luteal cells, the effect of serum-free medium with the antibody
storage buffer alone on corpora lutea in culture was also examined.

The

results indicated that the antibody storage buffer may have reduced the
occurrence of spontaneous apoptosis.

The anti-Fas monoclonal antibody appeared to further reduce
spontaneous apoptosis, although the results were not significant.

More

conclusive results may be obtained by extracting antibodies from the storage
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buffer before culture, thus removing the possible influence of the storage
buffer. Dose-response and time-response curves should also be produced to
better determine how varying concentrations of antibody and increasing time
affect spontaneous apoptosis. With these developments, the in vitro corpus
luteum culture model should prove to be an excellent system for investigating
the pathway(s) involved in Fas-mediated apoptosis.

Whilst a link has been shown between the Fas/Fas ligand system
and corpus Juteum function, it is important to remember that luteolysis is a
mu/lifactoria/ event.

Blocking the Fas receptor in vivo may not prevent

regression of the corpus Juteum.

Indeed, I am not aware of any reports of

fertility problems in lpr or gld mice, which carry mutations in Fas receptor and
Fas ligand respectively.

Nonetheless, both Fas receptor and Fas ligand appear to have a role in
corpus luteum function in the rat. As expression of both proteins increases
during natural regression in rat pregnancy and post-partum, a role in Juteolysis
is implicated. Future research is required in order to further define this role and
to relate the function of the Fas/Fas ligand system to the many factors which
influence the corpus Juteum.

As with many studies, the results of the present project have answered
some questions, but generated others.

For example, to what extent is the
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Fas/Fas ligand system involved in luteolysis? Is the Fas/Fas ligand system
involved in corpus luteum regression during the normal estrus cycle of the rat?
Are hormonal influences involved in the function of the Fas/Fas ligand system?
Can the molecular pathway(s) involved in Fas-mediated apoptosis be
identified? Is Fas ligand involved in immune privilege in the corpus luteum and
ovary?

With development of the in vitro corpus luteum culture model and

utilisation of gld and lpr mice, it would appear that in future studies the answers
to these questions will be within our reach.
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10.

APPENDIX 8- DETAILED PROTOCOLS

10.1. Immunohistochemistry

1.

Paraffin wax was removed from slides following the protocol shown in
Table 3.

Table 3
Protocol for Removal of Paraffin Wax from Sections

SOLUTION
Toluene
Toluene
100% Ethanol
100% Ethanol
70% Ethanol
Tap Water
Tap Water

2.

A circle was drawn around sections with a diamond pen, then slides
w~•re

3.

ACTION
Incubate 2 minutes
Incubate 2 minutes
Agitate 10 times
Agitate 10 times
Agttate 10 times
Agitate 10 times
Agitate 10 times

placed in distilled water.

Endogenous peroxidase activity was quenched by covering each section
with 250~L 3% Hydrogen Peroxide diluted in Methanol.

Slides were

incubated in a humidified chamber at room temperature for 10 minutes.
4.

Slides were washed in fresh PBS three times for 5 minutes each time.

5.

Staining for Fas receptor:

(a}

Sections were covered with 250~L 1% SDS to expose Fas antigen.
Slides were incubated in a humidified chamber at room temperature for 5
minutes.
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(b)

Slides were washed in fresh PBS three times for 5 minutes each time.

(c)

The primary antibody (Mouse anti-rat Fas monoclonal lgG, 250~g/ml)
was diluted 1 in 100 with PBS + 1% BSA. Sections on each test slide
were covered with

250~L

of diluted primary antibody.

negative control slides were covered with

250~L

Sections on

PBS + 1% BSA. Slides

were incubated in a humidified chamber at room temperature for 2
hours.
(d)

Test slides were washed in PBS for 10 minutes. Negative control slides
were left in the humidified chamber. All slides were then washed in fresh
PBS twice for 10 minutes each time.

(e)

The

secondary

antiboay

(Sheep

anti-mouse

immunoglobulins,

0.5mg/ml) was diluted 1 in 100 with PBS + 1% BSA +2% normal rat
serum (used to reduce nonspecific staining).

Sections were covered

wHh 250~L of diluted secondary antibody and incubated in a humidified
chamber at room temperature for 45 minutes.
6.

Staining for Fas ligand:

(a)

The primary antibody (Goat anti-rat Fas ligand polyclonal lgG,
200~g/ml)

was diluted 1 in 50 with PBS + 1% BSA. Sections on each

test slide were covered with

250~L

of diluted primary antibody. Sections

on negative control slides were covered with 25011L PBS + 1% BSA.
Slides were incubated in a humidified chamber at room temperature for 2
hours.

108

(b)

Test slides were washed in PBS for 10 minutes. Negative control slides
were left in the humidified chamber. All slides were then washed in fresh
PBS twice for 10 minutes each time.

(c)

The secondary antibody (Biotinylated rabbit anti-goat lgG, 1.5mg/ml)
was diluted 1 in 50 with PBS + 1% BSA + 2% normal rat serum.
Sections were covered with

250~l

of diluted secondary antibody and

incubated in a humidified chamber at room temperature for 45 minutes.
(d)

Slides were washed in fresh PBS three times for 5 minutes each time.

(e)

Streptavidin Horse Radish Peroxidase (HRP) conjugate was diluted 1 in
50 with PBS + 1% BSA. Sections were covered with

250~l

of diluted

Streptavidin-HRP and incubated in a humidified chamber at room
temperature tor 45 minutes.
7.

Staining for both Fas receptor and Fas ligand:
Slides were washed in fresh PBS three times for 5 minutes each time.

8.

1ml of 1Ox DAB was added to 9ml PBS. Just before use 5.5~l of
Hydrogen Peroxide was added to the DAB solution.

9.

Each section was covered with 500~l DAB solution.

Slides were

incubated in a humidified chamber at room temperature for 10 minutes.
10.

Slides were washed by dipping in fresh PBS once, then by placing in
fresh PBS twice for 5 minutes each time.

11.

Sections were counterstained with Haematoxylin and dehydrated
following the protocol shown in Table 4.

109

Table4
Protocol for Counterstaining and Dehydrating Sections

12.

SOLUTION

ACTION

Haematoxylin
Tap Water wash
Tap Water wash
70% Ethanol
100% Ethanol
100% Ethanol
100% Ethanol
100% Ethanol
Toluene
Toluene
Toluene

Incubate 2 seconds
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times
Agitate 10 times

Slides were coverslipped using DPX Mountant, then viewed by light
microscopy.

10.2. Relative Quantitative RT-PCR

RNA Extraction - RNAzol B Method
1.

Homogeniser probe was placed in Dimethyldicarbonate (DMDC)-treated
water for one hour to destroy any RNases present.

2.

Tissue was kept on ice until ready to homogenise.

3.

650~L of RNAzol B was added to each ovary before homogenising. A

further 650~L of RNAzol B was added to each tube and ovaries were
again homogenised briefly. Homogeniser probe was rinsed in DMDCtreated water between samples.
4.

130~L

of Chloroform was added to each tube and mixtures were shaken

vigorously for 15 seconds.
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5.

Tubes were incubated on ice for 5 minutes.

6.

Solutions were transferred to 2ml eppendorf tubes and centrifuged at
14,000rpm for 15 minutes.

7.

The upper aqueous phase of each tube was transferred to a new 2ml
eppendorftube and an equal volume of Isopropanol was added.

8.

Tubes were mixed, then incubated at 4"C for one hour.

9.

Tubes were centrifuged at 14,000rpm for 15 minutes.

10.

Solutions were decanted with care taken not to lose pellet.

11.

1ml of 75% cold Ethanol was added to each tube and solutions were
vortexed briefly.

12.

Tubes were centrifuged at 6,000rpm for 8 minutes.

13.

Solutions were decanted.

A pipette was used to remove excess

solution.
14.

Pellets were dried by placing open eppendorf tubes in a biohazard
cabinet for 15 minutes.

15.

Pellets were resuspended in 1O~L of DMDC-treated water.

16.

Quantitation and purity of isolated RNA was established with a Beckman
DU-640 Spectrophotometer.

Reverse Transcription Using Oligo-dT Primer
1.

2~L

ofOiigo-dT Primer,

500ng/~L

2.

2~g

of sample RNA was added to each tube. A negative control without

RNA was placed in each run.

was placed in each tube.

111

3.

The volume in each tube was made up to 1Opl with DMDC-treated
water.

4.

Tubes were placed in thermal cycler and incubated at ?o·c for 5
minutes, then placed on ice.

5.

15pl of a master mix of reagents was added to ,;ach tube.
Reverse Transcription Master Mix (A), 1x

6.

Reverse Transcriptase Buffer (5x)

5pl

dNTPs (5mM)

5pl

RNasin (40U/pl)

1pl

Sodium Pyrophosphate (40mM)

2.5pl

AMV Reverse Transcriptase (23U/pl)

1.5pl

Sample tubes were placed in thermal cycler on the following program:
(a) 42•c for 60 minutes
(b) 95•c for 5 minutes
(c)4•c 7.

7.

eDNA was stored at -2o•c.

Reverse Transcription Using Synthesized 3'-End Primers for Fas Ligand
1.

2.5pl of 3'-end primers for Fas ligand, 5pmol/pl was placed in each
tube.

2.

1pg of sample RNA was added to each tube. A negative control without
RNA was placed in each run.

3.

The volume in each tube was made up to 9pl with DMDC-treated water.
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4.

Tubes were placed in thermal cycler and incubated at 70'C for 5

minutes.
5.

16pl of a master mix of reagents was added to each tube.
Reverse Transcription Master Mix (B). 1x

6.

Reverse Transcriptase Buffer (5x)

5pl

dNTPs (5mM)

5pl

RNasin (40U/pl)

1pl

Sodium Pyrophosphate (40mM)

2.5pl

AMV Reverse Transcriptase (23U/pl)

2.5pl

Sample tubes were placed in thermal cycler on the following program:
(a) 42'C for 60 minutes
(b) 95'C for 2 minutes
(c) 4'C 7.

7.

eDNA was stored at -20'C.

PCR Using Fas Primers
1.

5pl of eDNA from each sample was amplified.

A negative control

substituting DMDC-treated water for eDNA an·d a positive control (diluted
10·', developed in the Molecular Biology Laboratory, Dept. of Anatomy
and Human Biology, University of Western Australia) were placed in
each run.
2.

20pl of a master mix of reagents was added to the eDNA in each tube.
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PCR Master Mix (A), 1x

3.

DMDC-Treated Water

11 .35~L

Taq Polymerase Buffer (10x)

2.5~L

MgCI2 (25mM)

4.0~L

dATP (100mM)

0. 1~L

dGTP (1 OOmM)

0.1~L

dTIP (100mM)

0. 1~L

dCTP (1 OOmM)

0.025~L

a 32P-dCTP (300mM)

0.075~L

Fas Primers (2pmoi/~L)

1.5~L

Taq Polymerase (5.5U/~L)

0.25~L

Sample tubes were placed in thennal cycler on the following program:
(a) 94oc for 4 minutes 30 seconds
(b) 94°C for 30 seconds
(c) 58°C for 45 seconds
(d) 72°C for 1 minute
(e) Steps (b) to (d) were repeated 35 times

(f)

noc for 5 minutes

(g) 4°C 7.
4.

Amplified samples were stored at -20°C.
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PCR Using Fas Ligand Primers
1.

2pl of eDNA from each sample was amplified.

A negative control

substituting DMDC-treated water for eDNA and a positive control (diluted
1o·•, developed in Molecular Biology Laboratory, Dept. of Anatomy and
Human Biology, University of Western Australia) was placed in each run.
2.

20pl of a master mix of reagents was added to the eDNA in each tube.
PCR Master Mix (B), 1x
DMDC-Treated Water

14.35pl

PLATINUM'" Taq Polymerase Buffer (10x)

2.5pL

MgCI2 (25mM)

2.5pL

dATP (100mM)

0.1pL

dGTP (1 OOmM)

0.1pl

dTIP (100mM)

0.1pl

dCTP (1 OOmM)

0.025pl

u 32 P.<JCTP (300mM)

0.075pL

Fas Ligand Primers (2pmol/pl)

3.0pL

Taq Polymerase (5.5U/pl)

3.

. 0.25pL

Sample tubes were placed in a thermal cycler on the following program:
(a) 94'C for 4 minutes 30 seconds
(b) 94'C for 30 seconds
(c) 58'C for 1 minute
(d) 72'C for 1 minute
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(e) Steps (b) to (d) were repeated 32times
(f) 72"C for 5 minutes

(g) 4"C 7.
4.

Amplified samples were stored at-20"C.

Isopropanol Extraction of Unincorporated Nucleotides from PCR Products
1.

18~L

2.

1.8~L

3.

20~L

4.

1~L

5.

Samples were incubated at4"C for 10 minutes.

6.

Samples were centrifuged at14,000rpm for 15 minutes.

7.

Supernatant was removed.

8.

Pellet was washed with

9.

Samples were centrifuged at14,000rpm for 5 minutes.

10.

Supernatant was removed.

11.

Samples were dessicated for 10-15 minutes in a biohazard cabinet.

12.

Pellet was resuspended in

of PCR product was placed into a clean eppendorf tube.
3M Sodium Acetate, pH 5.2, was added.
Isopropanol was added and solution was mixed.

Glycogen was added.

500~L

70% cold Ethanol, then vortexed.

15~L

ddH,O.

Running an Agarose Gel to Remove Unincorporated Nucleotides from PCR
Products
1.

Ends of a gel tray were sealed with autoclave tape and a comb placed
with the shorter edge of wells facing forward.
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2.

6~L

Ethidium Bromide per 100ml of a 1.5% Agarose in 1x TAE solution

was added and mixed without creating bubbles.
3.

Agarose gel was poured into gel tray without creating bubbles and gel
was allowed to harden for about 10 minutes.

4.

1x TAE was poured into electrophoresis chamber.

5.

Gel tray, with tape removed, was placed in electrophoresis chamber.

6.

Gel was just covered with 1x TAE.

7.

One drop of 6x Loading Dye was placed onto a sheet of parafilm.

8.

4~L

of PCR product was mixed with loading dye using a pipette, then

loaded into well.
9.

Steps 7 and 8 were repeated for each sample.

1u.

2~L

of 1kb Standard with loading dye was used as a marker for each

run.
11.

Gel was run at 70 - 80 volts for 35 minutes.

12.

The gel was viewed under UV light.

The Fas PCR product was 491

base pairs and the Fas ligand PCR product was 341 base pairs.
13.

Gel was placed on two pieces of blotting paper, which were cut so that
the edges extended 2 - 3 em around the gel.

14.

Gel and blotting paper were covered loosely in plastic wrap and dried in
a vacuum slab gel dryer for about 1 hour.
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15.

The radioactive gel was either exposed to x-ray film in an autoradiograph
cassette at -BO'C overnight, then developed, or exposed to a
phosphorimaging plate at room temperature overnight, then quantitated
using an image analysis computer program.

Relative Quantitative RT-PCR for Fas mRNA
1.

One sample from each time-point was reverse transcribed using the
protocol titled "Reverse Transcription Using Oligo-<JT Primer".

2.

Four-fold serial dilutions (i.e. neat,

1
1
1
/ 4 , / 16 , / 04 )

of each sample were

amplified by PCR using the protocol titled "PCR Using Fas Primers".
3.

Amplified products were run on an agarose gel and dried using the
protocol tilled "Running an Agarose Gel to Remove Unincorporated
Nucleotides from PCR Products", then quantitated after exposure to a
phosphorilnaging plate.

4.

Results were plotted on a logarithmic graph and a dilution amplifying
exponentially when the PCR reaction was stopped was chosen for each
time-point.

5.

All samples were reverse transcribed in the one run using the protocol
titled "Reverse Transcription Using Oligo-dT Primer".

6.

The eDNA of all samples was diluted to the factor chosen.

7.

All samples were amplified by PCR in one run using the protocol titled
"PCR Using Fas Primers".

118

8.

Amplified products were run on one agarose gel using the protocol titled
"Running an Agarose Gel to Remove Unincorporated Nucleotides from
PCR Products", then quantitated after exposure to a phosphorimaging
plate.

9.

Data from different time-points was compared after allowing for the
dilution factor used in the PCR reaction.

Relative Quantitative RT-PCR for Fas Ligand mRNA
1.

One sample from each time-point was reverse transcribed using the
protocol titled "Reverse Transcription Using Synthesized 3' -End Primers
for Fas Ligand".

2.

Four-fold serial dilutions (I.e. neat,

1
/4,

'I,., '164 ,

1
/ 128 )

of each sample were

amplified by PCR using the protocol titled "PCR Using Fas Ligand

Primers".
3.

The protocol titled "Isopropanol Extraction of Unincorporated Nucleotides
from PCR products" was followed and samples were quantitated with a
liquid scintillation counter.

4.

Results were plotted on a logarithmic graph and a dilution amplifying
exponentially when the PCR was stopped was chosen for each timepoint.

5.

All samples were reverse transcribed in one run using the protocol titled
"Reverse Transcription Using Synthesized 3'-End Primers for Fas
Ligand".
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6.

The eDNA of all samples was diluted to the factor chosen.

7.

All samples were amplified by PCR in one run using the protocol titled
"PCR Using Fas Ligand Primers".

8.

Amplified products were purified of unincorporated nucleotides using the
protocol titled "Isopropanol Extraction of Unincorporated Nucleotides
from PCR Products", then quantitated with a liquid scintillation counter.

9.

Data from different time-points was comr 6red after allowing for the
dilution factor used in the PCR reaction.

10.3. In Vitro Corpus Luteum Culture Model

Corpus Luteum In Vitro Cultyre Model
1.

Four sterile scintillation vials were prepared by adding 2ml serum-free
minimal essential medium (MEM) with 1~g/ml (a total of 40~L) anti-rat
Fas monoclonal antibody.

Another five sterile scintillation vials were

prepared with the addition of 2ml serum-free MEM and 40~L of antibody
storage buffer (50% glycerol, 20mM NaH 2P04 pH 7.5, 1.5mM NaN,,
1mg/ml BSA). Serum-free MEM only was added to a further five sterile
scintillation vials.
2.

Two corpora lutea were placed in each vial.

3.

The vials were gassed with a 95% 0 2 - 5% C02 mixture and their lids
sealed with vacuum grease.

4.

Vials were incubated under 95% 0 2 - 5% CO, at 37'C for 4 hours.
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5.

Corpora lutea were placed in sterile polypropylene tubes and snap
frozen in liquid nitrogen.

6.

Samples were stored at -ao·c.

DNA Extraction
1.

Each sample (consisting of two corpora lutea) was gently homogenised
in 670~L of DNA homogenisation buffer.

2.

Homogenate was transferred to a 2ml eppendorf tube and

42~L

of 10%

SDS was added and mixed.
3.

Tubes were incubated at 55•c for 30 minutes.

4.

119~L

5.

Tubes were incubated on Ice for 60 minutes.

6.

Tubes were microcentrifuged at 5,000rpm for 10 minutes.

7.

Supernatant was transferred to new tubes and divided in half.

8.

Equal volumes of Phenoi:Chloroform:lsoamyl alcohol (25:24:1) were

BM Potassium Acetate was added and mixed.

added to each tube and the solution was vortexed.
9.

Tubes were microcentrifuged at 6,000rpm for 5 minutes.

10.

The upper phase was transferred to a new tube.

11.

Equal volumes of Phenoi:Chloroform:lsoamyl alcohol (25:24:1) were
added to each tube and the solutions were vortexed.

12.

Tubes were microcentrifuged at 6,000rpm for 5 minutes.

13.

The upper phase was transferred to a new tube.
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14.

2.5x volume of cold 100% Ethanol was added and tubes were stored
overnight at -80"C.

15.

Tubes were microcentrifuged at 14,000rpm for 30 minutes.

16.

Solutions were decanted, while taking care not to lose pellet.

17.

100pl 1x TE, pH 8.0, was added and the pellet was resuspended.

18.

2pl RNase was added and r.olutions were vortexed.

19.

Tubes were microcentrifuged briefly, then incubated at 37"C for 60
minutes.

20.

Steps 7 to 12 were repeated.

21.

The upper phase was transferred to a new tube.

22.

0.1x volume 3M Sodium Acetate and 2.5x volume cold 100% Ethanol
was added and tubes were incubated at -80"C overnight.

23.

Tubes were microcentrifuged at 14,000rpm for 30 minutes.

24.

Solutions were decanted, taking care not to lose pellet.

25.

100pl cold 100% Ethanol was added without disrupting pellet.

26.

Tubes were placed on ice for 5 minutes, then centrifuged at 14,000rpm
for 5 minutes.

27.

Ethanol was decanted w~hout disrupting pellet, then tubes were inverted
over a paper towel to allow pellet to air dry for approximately 1 to 2
hours.

28.

Pellet was resuspended in 50pl ddH,O.

29.

Quantitation and purity of isolated DNA was established with a Beckman
DU-640 Spectrophotometer.

122

30.

Samples were stored at -SO'C.

3'-End Labelling
1.

1pg of each DNA sample was placed into eppendorf tubes. A sample of
DNA from rat corpora lutea which were immediately snap frozen after
dissection from the ovary (time zero) was included to be used as a
baseline measurement against which all samples would be compared.

2.

Volumes were made up to a total of 29pl with ddH20.

3.

10pl of 5x Terminal Transferase Reaction Buffer was added.

4.

5pl of CoCI, was added, then tubes were vortexed well.

5.

Tubes were microcentrifuged at 14,000rpm for 10 seconds.

6.

a32 P-ddATP (3,000 Ci/mmol) was diluted 1 in 8 and 5pl was added to
each tube.

7.

Terminal transferase was diluted 1 in 2 and 1pl was added to each tube.

8.

Tubes were vortexed, then microcentrifuged at 14,000rpm for 10
seconds.

9.

Tubes were incubated at 37'C for 60 minutes.

10.

5pl 0.25M EDTA was added.

11.

2pl !RNA solution was added.

12.

12pl 10M Ammonium Acetate was added.

13.

180pl cold 100% Ethanol was added.

14.

Tubes were placed in -SO'C for 60 minutes.

15.

Tubes were microcentrifuged at 14,000rpm for 20 minutes.
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16.

Supernatant was discarded.

17.

Pellet was resuspended in

18.

12~L

19.

180~L

20.

Tubes were vortexed, then placed in -ao•c for 60 minutes.

21.

Tubes were microcentrifuged at 14,000rpm for 20 minutes.

22.

Supernatant was discarded.

23.

Pellet was inverted over paper towel and allowed to air dry for 20

60~L

of 1x TE.

10M Ammonium Acetate was added.
of cold 100% Ethanol was added.

minutes.
24.

Pellet was resuspended in 40~L 1x TE and stored at -2o•c overnight.

25.

Samples were thawed for 30 minutes.

26.

Ends of a gel tray were sealed with autoclave tape and a comb placed at
one end.

27.

A 2% Agarose in 1x TAE gel was prepared, poured into the gel tray
without creating bubbles and allowed to set.

28.

1x TAE was poured into an electrophoresis chamber.

29.

Gel tray, with tape and comb removed, was placed into electrophoresis
chamber and gel was just covered with 1x TAE.

30.

Samples were vortexed, then microcentrifuged at 14,000rpm for 10
seconds.

31.

S~L

32.

Samples were votexed, then microcentrifuged at 14,000rpm for 10

of DNA loading buffer was added to each sample.

seconds.
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33.

20~L

of each sample was loaded into a well. The remaining volume of

each sample was stored at -20°C.
34.

Samples were electrophoresed at 50 volts for 2 hours 30 minutes.

35.

The gel was removed and placed onto two pieces of blotting paper,
which were cut so that the edges extended 2 - 3 em around the gel.

36.

Gel and blotting paper were covered loosely in plastic wrap and dried in
a vacuum slab gel dryer for 3 hours.

37.

Blotting paper was removed from gel and gel was covered with a new
piece of plastic wrap.

38.

The radioactive gel was taped inside an autoradiograph cassette and
exposed to X-ray film at -sooc overnight.

39.

The film was developed, viewed for laddering of low molecular weight
DNA, then placed under the gel in its original position.

40.

Each lane was marked using the autoradiograph as a guide.

41.

Low molecular weight DNA from each lane was excised using a scalpel,
then placed in a scintillation vial.

42.

The counts per minute of low molecular weight DNA for each sample
was obtained with a liquid scintillation counter.
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11.

APPENDIX C -SOLUTIONS AND BUFFERS

1.5% Aqarose Gel plus 1x TAE
Aqarose

1.5g

1xTAE

100ml

Place agarose in TAE and heat in microwave on medium setting until dissolved.

3,3'Diaminobenzidine Tetrahydrochloride (DAB), 10X
DAB

120mg

PBS

10ml

Dissolve DAB in PBS. Store in 1ml aliquots in freezer.
NB:

DAB is carcinogenic. Use a biohazard cabinet and wear gloves and a
face mask when weighing out powder.

Neutralise any item which

contacts powder or solution with 1 in 10 dilution of bleach after use.

Dimethyldicarbonate (DMDC) Treated Water
Add one part DMDC to 1000 parts double distilled water (ddH20). Autoclave
solution.
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DNA Homogentsation Buffer
NaC11M

50ml

EDTA 0.5M, pH 8.0

10ml

Tris 1M, pH 8.0

150ml

Sucrose 1M

100ml

Make up solution to 500mL by adding 190ml ddH,O.

DNA Loading Buffer
Glycerol (v:v)

30%

Bromophenol Blue (w:v)

0.25%

Xylene Cylanol (w:v)

0.25%

In Vitro Culture Mediurr

Minimal Essential Medium (Gibco}, 1x

100ml

(with Earle's salts, without L-glutamine,
without Phenol red)
Bovine Albumin, fatty acid free

100mg

L-glutamine, powdered

29.2mg

Sterile filter, then add:
Penicillin (5000U/ml)

200lll

Streptomycin (5000J1g/ml)

200lll

Store at 4•c.
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4% Paraformaldehyde
Sodium Phosphate Buffer, pH 7.2

100ml

Paraformaldehyde Powder

4g

Heat 50ml sodium phosphate buffer to BO'C. Add 4g paraformaldehyde and
dissolve with constant stirring. Add NaOH drop by drop until solution clears.
Cool solution and make up to 1OOml with sodium phosphate buffer. Use fresh
solution.
NB:

Paraformaldehyde is a possible mutagen, teratogen and carcinogen.

Use a biohazard cabinet and wear gloves and a face mask when weighing out
powder and preparing solution.

Phosphate Buffered Saline (PBS)
NaCI

B.Og

KCI

0.2g

Na 2HP04

1.6g

KH,PO,

0.2g

MgCI,

0.1g

CaCI2

0.1g

Dissolve salts individually in the order given in approximately 800ml of ddH,O.
Make up solution to 1 litre with ddH,O and adjust to pH 7.4 with NaOH. Use
fresh solution or autoclave before storage.
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PBS plus 1% Bovine Serym Albumin (PBS + 1% BSAl
PBS

100ml

BSA

1g

Dissolve BSA in PBS. Store aliquots at -20°C. Keep at 4°C when thawed.

Sodium Phosphate Buffer, pH 7.2
1M Na,HPO,

68.4ml

1M Na,H2PO,

31.6ml

Make solution up to 1 litre with ddH20.
TAE Buffer, 10x
Tris

. 48.4g

Glacial Acetic Acid

11.4ml

O.SM EDTA, pH 8.0

20ml

Make solution up to 1 litre with ddH,O.
TE, 1x
1M Tris-HCI, pH 8.0

5ml

O.SM EDTA, pH 8.0

1ml

Make up solution to 500ml by adding 494ml ddH20.

Tris-HCI
Use HCI to buffer Trizma Base to the required pH.
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12.

APPENDIX D- SUPPLIERS

12.1. Reagents

Reagent

Supplier

u 32P-dCTP

DuPont, USA

u 32P-ddATP

Amersham Life Science, UK

Agarose

Pharmacia Biotech, Sweden

Ammonium acetate

Sigma, USA

AMV reverse transcriptase

Promega, USA

Anti-rat Fas monoclonal antibody

Transduction Laboratories, UK

Anti-rat FasL polyclonal antibody

Santa Cruz Biotechnology, USA

Biotinylated rabbit anti-goat lgG

Vector Laboratories, USA

Bovine serum albumin

Sigma, USA

Bromophenol Blue

Sigma, USA

Calcium chloride (CaCI,)

Sigma, USA

Chloroform

Sigma, USA

Cobalt chloride (CoCI,)

Boehringer Mannheim, Germany

dATP

Promega, USA

dCTP

Promega, USA

dGTP

Promega, USA

Diaminobenzedine tetrahydrochloride (DAB) Sigma, USA
Disodium hydrogen phosphate (Na,HPO,)

BDH, Australia

DMDC

Sigma, USA
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DPX mountant

BDH, Australia

dTTP

Promega, USA

Ethanol

BDH, Australia

Ethidium bromide

Sigma, USA

Ethylenediaminetetraacetic Acid (EDTA)

Sigma, USA

Glacial Acetic Acid

BDH, Australia

Glycerol

Sigma, USA

Glycogen

Boehringer Mannheim, Germany

Haematoxylin

Australian Biostain, Australia

Hydrogen peroxide

Sigma, USA

lsoamylalchohol

Sigma, USA

Isopropanol

Sigma, USA

L-glutamine

Sigma, USA

Magnesium chloride (MgCI,)

Sigma, USA

Methanol

BDH, Australia

Minimal essential medium (MEM)

Gibco BRL, USA

0/igo-dT primers

Promega, USA

Paraffin wax

Oxford Labware, USA

Paraformaldahyde powder

Merck, Germany

Penicillin

ICN Pharmaceuticals, USA

Phenol

Sigma, USA

PLATINUMTM Taq polymerase

Gibco BRL, USA

Potassium acetate

Sigma, USA

Potassium chloride (KCI)

Ajax Chemicals, Australia
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Potassium dihydrogen orthophosphate

Ajax Chemicals, Australia

(KH,P04)
Reverse transcriptase buffer

Promega, USA

RNasin

Promega, USA

RNAzol B

Bresatec, Australia

Sheep anti-mouse immunoglobulins

Amersham Life Science, UK

Sodium acetate

Sigma, USA

Sodium azide (NaN,)

Sigma, USA

Sodium chloride (NaCI)

BDH, Australia

Sodium dihydrogen orthophosphate

BDH, Australia

(NaH,P0 4)
Sodium dodecyl sulfate (SDS)

Sigma, USA

Sodium pyrophosphate

Sigma, USA

Strepavidin HRP

Amersham Life Science, UK

Streptomycin

ICN Pharmaceuticals, USA

Taq polymerase

Gibco BRL, USA

Taq polymerase buffer

Gibco 'BRL, USA

Terminal transferase reaction buffer

Boehringer Mannheim, Germany

Toluene

BDH, Australia

Trizma Base

Sigma, USA

!RNA

Boehringer Mannheim, Germany

Xylene Cylanol

Sigma, USA
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12.2. Equipment

Equipment

Supplier

Audioradiograph Cassette

Kodak Scientific, Australia

Beckman DU-640 Spectrophotometer

Beckman Instruments Inc., USA

Incubator

Contherm Scientific Co., NZ

Gel Electrophoresis Apparatus, Easy Owl Scientific, Australia
Cast#B2
Mini-Gel Electrophoresis Apparatus

Pharmacia, Sweden

Incubator, Water jacketed, model 3157

Forma Scientific, USA

Light Microscope, Leitz Wetzler

Henderson Instrument Co., Australia

Liquid Scintillation Counter, Tri-Carb

Packard Laboratory Services,
Australia

Microcentifuge, 5415C
Programmable

Thermal

Eppendorf, Germany
Controller, MJ Research Inc., USA

PTC-100
P10, P200 and P1000 Pippettes, Biohit Locus Genex, Finland
Proline
Phosphorimager, Mac Bas 1000

Fuji Photofilm Co. Ltd., Japan

Bioimaging Analyser
Power Supply Module, 216A

BWD Electronics, Australia

Tissue Processor, Citadel 1000

Shandon Upshaw, USA

Slab-gel dryer, Uniequip 3040

Lab Supply, Australia
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Spencer 820 Microtome

American Optical Corporation, USA

Ultra-Turrax Homogeniser Probe

IKA®-Werk,

Janke

and

Kunkel

GmbH & Co .. , Germany
Vaccuum Embedder

Labec Laboratory Equipment,
Australia

Vortex Mixer- 16700 Mixer Thermolyne

Barnstead Thermolyne, USA
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13.

CONFERENCE ABSTRACT

Abstract accepted to the Combined Biological Sciences Meeting, August, 1997
in Fremanlle, W.A.:

ROLE OF FAS AND FAS LIGAND IN APOPTOSIS DURING LUTEOLYSIS
S. Roughton, A. Oharmarajan• and A. Bittles
Dept of Human Biology, Edith Cowan University, Joondalup, Westem Australia 6027
*Dept of Anatomy and Human Biology, University ofW.A., Nedlands, Western Australia 6009
Whilst apoptosis has been found to occur during structural regression of the corpus luteum (1),
the mechanisms involved have yet to be specified. One possible mediator is the Fas (or AP0-1
or CD95) receptor, a transmembrane protein which induces apoptosis in the cell when ligated.
As the Fas receptor is expressed in the regressing corpus luteum (CL} of the normal adult

human ovary (2), and Fas monoclonal antibodies induce apoptosis in cultured human granulosa
and luteal cells pretreated with interferon gamma (3), we hypothesized that the mechanism of
regression of the CL may involve Fas-mediated apoptosis. Th~ presence of Fas and Fas ligand
(FasL) in the rat CL at various stages of pregnancy and post-partum was examined
immunohistochemically. Steady state Fas and FasL mRNA levels in the rat ovary at various
stages of pregnancy and post-partum were analysed by semi-quantitative RT-PCR. The FasL
protein was localised in the rat CL throughout pregnancy and post-partum. In addition, mRNA
for Fasl was expressed at each time-point examined. The Fas receptor protein was localised in
the rat CL at one day post-partum, a period when the CL is undergoing maximal apoptosls.
Studies to date indicate that the Fas I Fasl system has a role in apoptosis during luteolysls.
Further investigations into the mechanisms of Fas-mediated CL apoptosis are currently being
undertaken.
1. Juengel, J.l., Garverick, H.A., Johnson, A.L., Youngquist, R.S. and Smllh, M.F. (1993).
Endocrinol. 132: 249-254.
2. Kondo, H., Marou, T., Peng, X. and Mochizuki, M. (1996). J. Clin. Endocrinol. Metab. 81:
2702-2710.
3. Quirk, S.M., Cowan, R.G., Joshi, S.G. and Henrikson, K.P. (1995). Bioi. Reprod. 52: 279-287.

